US20030033021A1 - Cartilage repair and regeneration scaffold and method - Google Patents

Cartilage repair and regeneration scaffold and method Download PDF

Info

Publication number
US20030033021A1
US20030033021A1 US10/195,334 US19533402A US2003033021A1 US 20030033021 A1 US20030033021 A1 US 20030033021A1 US 19533402 A US19533402 A US 19533402A US 2003033021 A1 US2003033021 A1 US 2003033021A1
Authority
US
United States
Prior art keywords
scaffold
defect
biological lubricant
biological
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/195,334
Inventor
Pamela Plouhar
Herbert Schwartz
Prasanna Malaviya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DePuy Products Inc
Original Assignee
Plouhar Pamela Lynn
Schwartz Herbert Eugene
Prasanna Malaviya
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plouhar Pamela Lynn, Schwartz Herbert Eugene, Prasanna Malaviya filed Critical Plouhar Pamela Lynn
Priority to US10/195,334 priority Critical patent/US20030033021A1/en
Publication of US20030033021A1 publication Critical patent/US20030033021A1/en
Assigned to DEPUY PRODUCTS, INC. reassignment DEPUY PRODUCTS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PLOUHAR, PAMELA L., MALAVIYA, PRASANNA, SCHWARTZ, HERBERT E.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843Connective tissue
    • A61L27/3852Cartilage, e.g. meniscus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064Surgical staples, i.e. penetrating the tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064Surgical staples, i.e. penetrating the tissue
    • A61B17/0642Surgical staples, i.e. penetrating the tissue for bones, e.g. for osteosynthesis or connecting tendon to bone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0063Implantable repair or support meshes, e.g. hernia meshes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/08Muscles; Tendons; Ligaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/08Muscles; Tendons; Ligaments
    • A61F2/0811Fixation devices for tendons or ligaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30721Accessories
    • A61F2/30749Fixation appliances for connecting prostheses to the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30756Cartilage endoprostheses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/38Joints for elbows or knees
    • A61F2/3872Meniscus for implantation between the natural bone surfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633Extracellular matrix [ECM]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3645Connective tissue
    • A61L27/3654Cartilage, e.g. meniscus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/005Ingredients of undetermined constitution or reaction products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0401Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06166Sutures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00004(bio)absorbable, (bio)resorbable, resorptive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/0469Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery
    • A61B2017/0475Suturing instruments for use in minimally invasive surgery, e.g. endoscopic surgery using sutures having a slip knot
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B2017/06057Double-armed sutures, i.e. sutures having a needle attached to each end
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064Surgical staples, i.e. penetrating the tissue
    • A61B2017/0641Surgical staples, i.e. penetrating the tissue having at least three legs as part of one single body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064Surgical staples, i.e. penetrating the tissue
    • A61B2017/0646Surgical staples, i.e. penetrating the tissue for insertion into cartillege, e.g. meniscus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064Surgical staples, i.e. penetrating the tissue
    • A61B2017/0647Surgical staples, i.e. penetrating the tissue having one single leg, e.g. tacks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2/30965Reinforcing the prosthesis by embedding particles or fibres during moulding or dipping
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/442Intervertebral or spinal discs, e.g. resilient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2002/2817Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2002/2835Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material
    • A61F2002/2839Bone plugs or bone graft dowels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/30004Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
    • A61F2002/30032Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis differing in absorbability or resorbability, i.e. in absorption or resorption time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006Properties of materials and coating materials
    • A61F2002/30062(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/3011Cross-sections or two-dimensional shapes
    • A61F2002/30112Rounded shapes, e.g. with rounded corners
    • A61F2002/30131Rounded shapes, e.g. with rounded corners horseshoe- or crescent- or C-shaped or U-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/3011Cross-sections or two-dimensional shapes
    • A61F2002/30138Convex polygonal shapes
    • A61F2002/30153Convex polygonal shapes rectangular
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/30199Three-dimensional shapes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/30199Three-dimensional shapes
    • A61F2002/30205Three-dimensional shapes conical
    • A61F2002/3021Three-dimensional shapes conical frustoconical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/30199Three-dimensional shapes
    • A61F2002/30205Three-dimensional shapes conical
    • A61F2002/30217Three-dimensional shapes conical hollow cones, e.g. tubular-like cones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/30199Three-dimensional shapes
    • A61F2002/30224Three-dimensional shapes cylindrical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/30199Three-dimensional shapes
    • A61F2002/30224Three-dimensional shapes cylindrical
    • A61F2002/30225Flat cylinders, i.e. discs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/30199Three-dimensional shapes
    • A61F2002/30224Three-dimensional shapes cylindrical
    • A61F2002/30233Stepped cylinders, i.e. having discrete diameter changes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/30199Three-dimensional shapes
    • A61F2002/30261Three-dimensional shapes parallelepipedal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/30199Three-dimensional shapes
    • A61F2002/3028Three-dimensional shapes polyhedral different from parallelepipedal and pyramidal
    • A61F2002/30281Three-dimensional shapes polyhedral different from parallelepipedal and pyramidal wedge-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/30199Three-dimensional shapes
    • A61F2002/30291Three-dimensional shapes spirally-coiled, i.e. having a 2D spiral cross-section
    • A61F2002/30293Cylindrical body made by spirally rolling up a sheet or a strip around itself
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/30199Three-dimensional shapes
    • A61F2002/30291Three-dimensional shapes spirally-coiled, i.e. having a 2D spiral cross-section
    • A61F2002/30294Conical or frustoconical body made by spirally rolling up a sheet or a strip around itself
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30329Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • A61F2002/30428Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by inserting a protrusion into a slot
    • A61F2002/30429Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by inserting a protrusion into a slot made by inserting a hook into a cooperating slot
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30535Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30604Special structural features of bone or joint prostheses not otherwise provided for modular
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30667Features concerning an interaction with the environment or a particular use of the prosthesis
    • A61F2002/30677Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30721Accessories
    • A61F2/30749Fixation appliances for connecting prostheses to the body
    • A61F2002/30751Fixation appliances for connecting prostheses to the body for attaching cartilage scaffolds to underlying bone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30756Cartilage endoprostheses
    • A61F2002/30764Cartilage harvest sites
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30756Cartilage endoprostheses
    • A61F2002/30766Scaffolds for cartilage ingrowth and regeneration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • A61F2002/30772Apertures or holes, e.g. of circular cross section
    • A61F2002/30784Plurality of holes
    • A61F2002/30785Plurality of holes parallel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • A61F2002/30841Sharp anchoring protrusions for impaction into the bone, e.g. sharp pins, spikes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • A61F2002/30841Sharp anchoring protrusions for impaction into the bone, e.g. sharp pins, spikes
    • A61F2002/30845Sharp anchoring protrusions for impaction into the bone, e.g. sharp pins, spikes with cutting edges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • A61F2002/30878Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves with non-sharp protrusions, for instance contacting the bone for anchoring, e.g. keels, pegs, pins, posts, shanks, stems, struts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • A61F2002/30878Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves with non-sharp protrusions, for instance contacting the bone for anchoring, e.g. keels, pegs, pins, posts, shanks, stems, struts
    • A61F2002/30891Plurality of protrusions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30771Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
    • A61F2002/30878Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves with non-sharp protrusions, for instance contacting the bone for anchoring, e.g. keels, pegs, pins, posts, shanks, stems, struts
    • A61F2002/30891Plurality of protrusions
    • A61F2002/30892Plurality of protrusions parallel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2/30907Nets or sleeves applied to surface of prostheses or in cement
    • A61F2002/30909Nets
    • A61F2002/30914Details of the mesh structure, e.g. disposition of the woven warp and weft wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2/30942Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques
    • A61F2002/30957Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques using a positive or a negative model, e.g. moulds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2/30942Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques
    • A61F2002/3096Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques trimmed or cut to a customised size
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2002/30971Laminates, i.e. layered products
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2002/30975Designing or manufacturing processes made of two halves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2220/00Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2220/0025Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0013Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0017Angular shapes
    • A61F2230/0019Angular shapes rectangular
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0067Three-dimensional shapes conical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0069Three-dimensional shapes cylindrical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0082Three-dimensional shapes parallelepipedal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0086Pyramidal, tetrahedral, or wedge-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0091Three-dimensional shapes helically-coiled or spirally-coiled, i.e. having a 2-D spiral cross-section
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2240/00Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2240/001Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2240/00Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2240/001Designing or manufacturing processes
    • A61F2240/002Designing or making customized prostheses
    • A61F2240/004Using a positive or negative model, e.g. moulds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/003Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in adsorbability or resorbability, i.e. in adsorption or resorption time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/006Additional features; Implant or prostheses properties not otherwise provided for modular
    • A61F2250/0063Nested prosthetic parts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067Means for introducing or releasing pharmaceutical products into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00365Proteins; Polypeptides; Degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/06Materials or treatment for tissue regeneration for cartilage reconstruction, e.g. meniscus

Definitions

  • Articular cartilage is a type of hyaline cartilage that lines the surfaces of the opposing bones in a diarthrodial joint (e.g. knee, hip, shoulder, etc.). Articular cartilage provides a near-frictionless articulation between the bones, while also functioning to absorb and transmit the compressive and shear forces encountered in the joint. Further, since the tissue associated with articular cartilage is aneural, these load absorbing and transmitting functions occur in a painless fashion in a healthy joint.
  • Fibrocartilage is found in diarthrodial joints, symphyseal joints, intervertebral discs, articular discs, as inclusions in certain tendons that wrap around a pulley, and at insertion sites of ligaments and tendons into bone.
  • fibrocartilage can also be damaged, causing pain in the affected joint. It is understood for purposes of this application that the term “cartilage” includes articular cartilage and fibrocartilage.
  • cartilage tissue When cartilage tissue is no longer healthy it can cause debilitating pain in the joint.
  • articular cartilage health can be affected by disease, aging, or trauma, all of which primarily involve a breakdown of the matrix consisting of a dense network of proteoglycan aggregates, collagen fibers, and other smaller matrix proteins.
  • Tissue cells are unable to induce an adequate healing response because they are unable to migrate, being enclosed in lacunae surrounded by a dense matrix.
  • initiation of healing by circulating cells is limited.
  • damage or degeneration of knee fibrocartilage i.e. the menisci, is a common occurrence.
  • a damaged or degenerated meniscus has little ability to heal or repair itself because the pathology frequently occurs in the avascular part of the tissue.
  • FIG. 1 Another surgical technique is mosaicplasty or osteochondral autograft transfer system (OATS).
  • OATS osteochondral autograft transfer system
  • cylindrical plugs of healthy articular cartilage from a low-load bearing region of the knee are taken and transplanted into the defective region.
  • This technique can result in excessive donor-site morbidity and associated pain.
  • surgeons have reported that the gaps between the round transplants are frequently filled with fibrocartilage which can eventually erode away, thus potentially compromising the integrity of repair throughout the affected area.
  • the scaffold material can be a purified biologic polymer in the form of a porous scaffold or a gel (purified collagens, glycoproteins, proteoglycans, polysaccharides, or the like in various combinations) or porous scaffolds of synthetic biodegradable polymers (PLA, PGA, PDS, PCL, or the like, in various combinations).
  • U.S. Pat. No. 6,042,610 to ReGen Biologics discloses the use of a device to regenerate meniscal fibrocartilage.
  • the disclosed device comprises a bioabsorbable material made at least in part from purified collagen and glycosaminoglycans (GAG).
  • GAG glycosaminoglycans
  • Purified collagen and glycosaminoglycans are co-lyophilized to create a foam and then cross-linked to form the device.
  • the device can be used to provide augmentation for a damaged meniscus.
  • Related U.S. Pat. Nos. 5,735,903, 5,479,033, 5,306,311, 5,007,934, and 4,880,429 also disclose a meniscal augmentation device for establishing a scaffold adapted for ingrowth of meniscal fibrochondrocyts.
  • ECMs extracellular matrices
  • SIS small intestine submucosa
  • the SIS material is reported to be a naturally-occurring collagenous matrix derived from porcine small intestinal submucosa that models the qualities of its host when implanted in human soft tissues.
  • the SIS material provides a natural matrix with a three-dimensional structure and biochemical composition that attracts host cells and supports tissue remodeling.
  • SIS products such as Oasis material and Surgisis material, are commercially available from Cook Biotech, Bloomington, Ind.
  • RESTORE Orthobiologic Implant is available from DePuy Orthopaedics, Inc. in Warsaw, Ind. The DePuy product is described for use during rotator cuff surgery, and is provided as a resorbable framework that allows the rotator cuff tendon to regenerate itself.
  • the RESTORE Implant is derived from porcine small intestine submucosa that has been cleaned, disinfected, and sterilized. Small intestine submucosa (SIS) has been described as a naturally-occurring ECM composed primarily of collagenous proteins. Other biological molecules, such as growth factors, glycosaminoglycans, etc., have also been identified in SIS.
  • tissue remodeling While small intestine submucosa is available, other sources of submucosa are known to be effective for tissue remodeling. These sources include, but are not limited to, stomach, bladder, alimentary, respiratory, or genital submucosa, or liver basement membrane. See, e.g., U.S. Pat. Nos. 6,171,344, 6,099,567, and 5,554,389, hereby incorporated by reference. Further, while SIS is most often porcine derived, it is known that these various submucosa materials may be derived from non-porcine sources, including bovine and ovine sources. Additionally, other collagenous matrices are known, for example lamina limbal, and stratum compactum.
  • GAG glycosaminoglycans
  • HA hyaluronic acid
  • dermatan sulfate heparan sulfate
  • chondroiton sulfates keratin sulfate
  • keratin sulfate etc.
  • GAGs are naturally found mostly in the extracellular matrix and on the cell surface as proteoglycans. These macromolecules are secreted by cells and play a role in both signal transduction and storage of some growth factors.
  • HA is a linear polymer made up of repeating GAG disaccharide units of D-glucuronic acid and N-acetylglycosamine in ⁇ (1-3) and ⁇ (1-4) linkages.
  • HA can have a molecular weight ranging from about 300,000 kDa to about 6,000,000 kDa and can be uncrosslinked, naturally crosslinked, or crosslinked using mechanical, chemical, or enzymatic methods.
  • the combination of a biocompatible scaffold and HA produces a synergistic effect. Healing rates and/or quality of healing is better than the healing expected from additive effects of the scaffold or HA alone. Moreover, it has been found that retention of HA at the defect site is not problematic and co-administration of the scaffold and HA does not require HA to be cross-linked to the scaffold material.
  • the present invention provides methods for the repair of damaged or diseased cartilaginous tissue, wherein a biocompatible scaffold and HA are co-administered to the cartilaginous tissue defect.
  • GAGs such as dermatan sulfate, heparan sulfate, chondroitin sulfate, and keratan sulfate are also expected to be usable with the present invention.
  • biological lubricant is used to identify the aforementioned materials and others such as synovial fluid and components thereof, including mucinous glycoproteins (for example lubricin), tribonectins, articular cartilage superficial zone proteins, surface-active phospholipids, and lubricating glycoproteins I, II; vitronectin; and rooster comb hyaluronate (e.g.
  • biological lubricant is intended to encompass materials that provide some biological function (influencing cellular behavior) and some mechanical function (lubrication).
  • ARTHREASETM high molecular weight sodium hyaluronate
  • SYNVISC® Hylan G-F 20, manufactured by Biomatrix, Inc., of Ridgefield, N.J. and distributed by Wyeth-Ayerst Pharmaceuticals of Philadelphia, Pa.
  • HYLAGAN® sodium hyaluronate available from Sanofi-Synthelabo, Inc., of New York, N.Y.
  • HA HA
  • GAG biological lubricant
  • the three-dimensional biologic or synthetic scaffolds may be provided in the form of a fibrous nonwoven or foam material.
  • the scaffold preferably has interconnecting pores or voids to facilitate the transport of nutrients and/or invasion of cells into the scaffold.
  • the interconnected voids range in size, for example, from about 20 to 400 microns, illustratively 50 to 250 microns, depending on the application.
  • the range of the void size in the construct can be manipulated by changing process steps during construct fabrication. See Ser. No. ______ entitled “Porous Delivery Scaffold and Method” (Attorney Docket No. 265280-71207, DEP-762), already incorporated by reference.
  • the foam optionally may be formed around a reinforcing material, for example, a knitted mesh or an ECM layer.
  • a reinforcing material for example, a knitted mesh or an ECM layer.
  • the fibers used to make the scaffold can be made of any biocompatible material, including bioabsorbable materials such as polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyvinyl alcohol (PVA), copolymers or blends thereof, or combinations of synthetic and biologic polymers. See also, Ser. No.
  • the biologic polymers may comprise ECM, particularly comminuted ECM.
  • the fibers that comprise scaffold are formed of a polylactic acid and polyglycolic acid copolymer at a 95:5 mole ratio.
  • a method is provided wherein the scaffold material is implanted into the defect.
  • the biological lubricant which can be a GAG or HA for example, is administered separately, either at the time of surgery or via injection subsequent to closure of the incision.
  • a series of additional injections may be administered over a period of time. In either case, the injection may be made intra-articularly.
  • a method wherein the scaffold material and the biological lubricant are administered to the defect together.
  • the scaffold material may be saturated with the biological lubricant at the time of surgery.
  • the scaffold material may be saturated with the biological lubricant at the time of manufacture, and may be packaged together.
  • a series of additional injections may be administered in this method as well.
  • an implantable device comprising a scaffold material saturated with a biological lubricant.
  • FIG. 1 is a diagrammatical view showing a tibial platform with a typical meniscus structure on the platform and a portion of the meniscus removed for illustration purposes, the tibia platform being below the condyles of the femur;
  • FIG. 2 is a view looking down at the tibial platform and showing diagrammatically the insertion of a scaffold to replace the portion of the meniscus removed;
  • FIG. 3 shows the inserted scaffold in a position to be attached to the portions of the meniscus remaining after the injured portion is removed;
  • FIG. 4 is a sectional view taken from FIG. 3 along the lines 4 - 4 ;
  • FIG. 5 is a perspective view showing an open wedge-shaped device comprising an upper panel and a lower panel angularly separated to define an apex portion and a base portion;
  • FIG. 6 shows a wedge shaped device prior to folding with a pocket shown in imaginary lines formed in the device
  • FIG. 7 shows a further step in the process in making the device shown in FIG. 6 to produce a filled, wedge-shaped device
  • FIG. 8 is a top view of a ECM device used for the repair of a meniscal defect and having barbs for attachment;
  • FIG. 9 is a top view of a device similar to that shown in FIG. 1, except having sutures for attachment;
  • FIG. 10 is a perspective, partially cut-away view of a meniscus with the device of FIG. 1 inserted into the meniscus;
  • FIG. 11 is a cross sectional view of a cartilage repair device implanted in subchondral bone, note that the anchor is shown in elevation rather than cross section for clarity of description;
  • FIG. 12 is a cross sectional view of a cartilage repair device which uses an alternative embodiment of an anchor.
  • a tibial platform 10 below the condyles 12 of a knee support a meniscus 11 from which an illustrative defective portion 14 is removed to leave a wedge-shaped space 16 .
  • the surgeon will often leave an outer rim 18 of the meniscus.
  • the meniscus provides a large surface of articulation between the otherwise incongruent surfaces of the tibia platform or plateau and the femur condyles (such indicated at 12 ).
  • the meniscus serves to reduce contact stresses and wear in the knee joint.
  • the portion 14 removed from the structure shown in FIG. 1 includes a portion of the original meniscus which was within the avascular zone, particularly the radially inner portion, and may include a portion of the original meniscus which was within the vascular zone.
  • FIG. 2 shows how a scaffold device 20 may illustratively be inserted into the space 16 to be against the outer rim 18 .
  • This illustrative scaffold 20 is shown in FIGS. 3 and 4 in position filling the space 16 and against the rim 18 left by the surgeon.
  • FIG. 4 shows the scaffold as comprising an upper cover or upper panel 22 and a lower cover or lower panel 24 .
  • These panels 22 , 24 which may illustratively be angularly related, will define an internal space 26 between the covers.
  • Internal space 26 optionally may be filled with a biological material, a biological structure, or a synthetic structure providing a framework for regeneration of the meniscus into the space 16 .
  • panels 22 , 24 may be made from woven or nonwoven mats of synthetic polymer or synthetic/biologic polymers.
  • scaffold 20 may be constructed by forming the synthetic or synthetic/biologic polymers in a mold, or by sculpting a block of the polymer into the proper shape.
  • the scaffolds may comprise synthetic polymers such as polylactic acid (PLA), polyglocolic acid (PGA), polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyvinyl alcohol (PVA), and copolymers and blends thereof.
  • the synthetic polymers may be provided as textiles with woven, knitted, warped knitted, nonwoven, braided, and foamed structures, and illustratively may be imbedded in ECM material, as in copending U.S. patent application Ser. No. 10/172,347 entitled “Hybrid Biologic-Synthetic Bioabsorbable Scaffolds” which was filed on Jun.
  • the scaffold may be made of biocompatible polymers, with or without a biologic component, and may be provided in a variety of woven, knitted, nonwoven, braided formed, or molded, or other configurations.
  • Scaffold 20 may be inserted, for example, in arthroscopic surgery through portals provided in the outer anterior surface of the knee opening into the knee cavity between the condyles 12 and the tibial platform 10 .
  • the upper cover 22 of the scaffold 20 may serve as a bearing surface for the condyle 12 disposed thereabove and be subjected to the compression and stress forces involved in articulation of the knee. The condyle will move upon the upper surface of the cover 22 .
  • FIGS. 5, 6 and 7 it will be seen that an illustrative device is somewhat diagrammatically illustrated.
  • the illustrative device 30 includes an upper panel 32 and a lower panel 34 defining a wedge-shaped device having a base portion 36 and an apex portion 38 .
  • FIG. 6 suggests that the device may include a formed wedge-shaped cavity 39 (illustrated in phantom) and that the device may be folded about a fold line 40 to provide a device such as indicated at 42 in FIG. 7.
  • the FIG. 5 device 30 suggests an open wedge-shaped design
  • the device 42 in FIG. 7 suggests that, between the upper and lower panels 32 , 34 a mass of biological material may be disposed.
  • a plurality of tacks 44 are shown attached to one of the two panels of the device to be used for securing the device to surrounding tissue in the knee.
  • the panels 32 , 34 may be trimmed to the desired wedge shape.
  • FIGS. 8 - 10 there are shown scaffolds similar to those shown in FIGS. 6 - 7 , except that device 100 need not be wedge shaped.
  • Scaffold 100 comprises panels 102 and 104 , with a pillow 106 of biological or synthetic material shaped to fill the void in meniscus 111 left after a partial menisectomy, as illustrated in FIG. 1.
  • the pillow is placed between panels 102 and 104 .
  • pillow 106 is smaller than panels 102 and 104 , and wing portions 105 of panels 102 and 104 extend beyond pillow 106 .
  • scaffold 100 may be provided with barbed darts 112 extending from wings 105 .
  • a needle or similar device would be used to push the barbed darts 112 into or through the meniscus to secure scaffold 100 to the meniscus.
  • Barbed darts may be made of any biocompatible material sufficiently rigid to secure scaffold 100 to the meniscus.
  • Barbed darts 112 may be provided integrally with scaffold 100 or may be added by the surgeon prior to insertion of the device.
  • the scaffold 100 illustrated in FIG. 9 is similar to the scaffold shown in FIG. 8, except that instead of barbed darts, the scaffold of FIG. 9 is provided with sutures 113 .
  • the scaffold of FIG. 9 may be affixed to the meniscus in a manner similar to that of the scaffold of FIG. 8.
  • a needle or similar device would be used to push the sutures 113 through the meniscus.
  • the sutures may be tied together on the outside of the meniscus to form knots 120 that secure scaffold 100 in place.
  • FIGS. 11 and 12 illustrate several scaffolds that can be used in conjunction with a biological lubricant for cartilage repair.
  • a cartilage repair device 210 is provided for repairing damaged or diseased cartilage.
  • the device 210 includes an anchor 212 which is anchored or otherwise positioned in an opening formed in both a section of native cartilage 216 and the underlying subchondral bone 218 .
  • the anchor 212 is configured to be secured in an area from which damaged, diseased, or destroyed native cartilage and possibly bone have been removed.
  • the anchor 212 includes an elongated central body portion 220 and a head portion 222 .
  • the body portion 220 extends downwardly from a lower surface of the head portion 222 . As shown in FIG.
  • the body portion 220 may have a number of barbs 224 extending therefrom for engaging the sidewalls of the opening formed in the bone 218 .
  • the barbs 224 extend radially outwardly and are inclined slightly toward the head portion 222 of the anchor 212 .
  • the cartilage repair device 210 also includes a plug 226 .
  • the plug 226 is secured to the anchor 212 .
  • the plug 226 is secured to the upper surface of the head portion 222 of the anchor 212 .
  • the plug 226 allows for communication across the removed portion (i.e., the portion of the native cartilage 216 from which the damaged or diseased cartilage has been removed) and the adjacent healthy cartilage.
  • the plug 226 functions as a chondrogenic growth-supporting matrix for promoting a positive cellular response in an effort to achieve articular cartilage regeneration.
  • the anchor 212 of the cartilage repair device 210 may be constructed of numerous types of synthetic or naturally occurring materials.
  • the anchor 212 may be constructed with a bioabsorbable polymer.
  • examples of such polymers include: polyesters of [alpha]-hydroxycarboxylic acids, such as poly(L-lactide) (PLLA), polyglycolide (PGA); poly-p-dioxanone (PDS); polycaprolactone (PCL); and any other bioresorbable and biocompatible polymer, co-polymer or mixture of polymers or co-polymers that are commonly used in the construction of prosthetic implants.
  • the anchor 212 may be constructed with a naturally occurring material such as a naturally occurring ECM (e.g., SIS).
  • ECM e.g., SIS
  • the head portion 222 and body portion 220 of the anchor 212 may be configured as monolithic structures formed from naturally occurring ECM which is cured to be rigid and hardened to facilitate attachment to the bone 218 .
  • the ECM material from which the anchor 212 is fabricated is cured to produce a structure which possesses the necessary hardness and toughness to allow the anchor 212 to be driven into bone tissue (i.e., the subchondral bone 218 ). See U.S. patent application Ser. No. ______ entitled “Devices from Naturally Occurring Biologically Derived Materials” (Attorney Docket No. 265280-71142, DEP-748), already incorporated by reference.
  • the material selected for the anchor 212 may also comprise mixtures or composites of materials.
  • the anchor 212 could comprise both a polymer and ECM material.
  • the plug 226 which is fixed to the anchor 212 , functions as a chondrogenic growth-supporting matrix for promoting vascular invasion and cellular proliferation in an effort to achieve articular cartilage regeneration.
  • a central body 230 of the plug 226 is configured as a porous structure of biodegradable material. When anchored to a defective area of cartilage, cells can migrate into and proliferate within the plug 226 , biodegrade the plug 226 while, at the same time, synthesize new and healthy tissue to heal the defective area.
  • the plug 226 may be made out of a nonwoven or foam scaffold of synthetic or synthetic/biologic fibers with the desired porosity and material density.
  • the material density and/or porosity of the plug 226 may be varied to control cell migration and proliferation.
  • the cells can migrate from adjacent tissue or from synovial fluid.
  • the fibers from which the plug 226 is constructed also may be formed to have a structural rigidity sufficient to withstand the compression and shear stress to which the cartilage 216 is subjected. As such, the porous material from which the plug 226 is constructed should have the structural rigidity necessary to bear the forces associated with the other bone.
  • One particularly useful material for fabricating the plug 226 is a porous scaffold or “foam” composed of synthetic fibers or a combination of synthetic fibers and naturally occurring ECM. Both the material density and the pore size of the foam plug 226 may be varied to fit the needs of a given plug design. Such foams may be fabricated by lyophilizing (i.e., freeze-drying) the fibers suspended in water. The material density and pore size of the resultant foam may be varied by controlling, among other things, the rate of freezing of the fiber suspension and/or the amount of water or moisture content in the fiber suspension at the on-set of the freezing process. See U.S. patent application Ser. No.
  • FIG. 12 there is shown another embodiment of a cartilage repair device (hereinafter referred to with reference numeral 410 ).
  • the cartilage repair device 410 is somewhat similar to the cartilage repair device 210 .
  • the same reference numerals are used in FIG. 12 to identify components which have previously been discussed, with additional discussion thereof being unwarranted.
  • the cartilage repair device 410 includes an anchor 412 which is used in lieu of the anchor 212 described in regard to FIG. 11.
  • the plug 226 is positioned in an osteochondral defect 414 without the use of a bottom-mounted anchor (i.e., the anchor 212 of FIG. 11).
  • the plug 226 is constructed out of synthetic fibers or a combination of synthetic fibers and naturally occurring ECM (e.g., SIS) having a desired porosity and material density.
  • ECM e.g., SIS
  • the plug 226 is retained in the hole formed in the cartilage 216 and protected from in vivo forces by an annular shaped anchor 412 .
  • the anchor 412 may be provided in many different configurations which allow it to be press fit or otherwise anchored into the subchondral bone 218 .
  • the anchor 412 may be “bottle cap”-shaped so as to allow the anchor 412 to be press fit or otherwise secured into an annular groove 416 formed in the subchondral bone 218 .
  • the groove may be formed and the anchor may be shaped as described and shown in Patent Cooperation Treaty publication WO 01/39694 A2, published Jun. 7, 2001 entitled “Fixation Technology”, the complete disclosure of which is incorporated by reference herein.
  • the anchor 412 may be mechanically secured to the subchondral bone 218 by use of adhesive or other types of anchoring structures (e.g., barbs).
  • the anchor 412 of the cartilage repair device 410 may be constructed from numerous types of synthetic or naturally occurring materials.
  • the anchor 212 may be constructed with a bioabsorbable polymer such as PLLA, PGA, PDS, PCL, or any other such bioabsorbable polymer which is commonly used in the construction of prosthetic implants.
  • the anchor 412 may be constructed from a naturally occurring material such as a naturally occurring ECM (e.g., SIS) that is cured or otherwise fabricated to be rigid and hardened to facilitate attachment to the bone in the same manner as described above in regard to the anchor 212 and/or the plug 226 of FIG. 11.
  • a naturally occurring ECM e.g., SIS
  • bioactive agents may be combined with the scaffold material or biological lubricant.
  • bioactive agents may be mixed with the scaffold material or biological lubricant.
  • biocompatible inorganic material may be mixed with the scaffold material or biological lubricant.
  • Bioactive agents include one or more of the following: chemotactic agents; therapeutic agents (e.g. antibiotics, steroidal and non-steroidal analgesics and anti-inflammatories, anti-rejection agents such as immunosuppressants and anti-cancer drugs); various proteins (e.g. short chain peptides, bone morphogenic proteins, glycoprotein and lipoprotein); cell attachment mediators; biologically active ligands; integrin binding sequence; ligands; various growth and/or differentiation agents (e.g.
  • epidermal growth factor IGF-I, IGF-II, TGF- ⁇ I-III, growth and differentiation factors, vascular endothelial growth factors, fibroblast growth factors, platelet derived growth factors, insulin derived growth factor and transforming growth factors, parathyroid hormone, parathyroid hormone related peptide, bFGF; TGF ⁇ superfamily factors; BMP-2; BMP-4; BMP-6; BMP-12; sonic hedgehog; GDF5; GDF6; GDF8; PDGF); small molecules that affect the upregulation of specific growth factors; tenascin-C; hyaluronic acid; chondroitin sulfate; fibronectin; decorin; thromboelastin; thrombin-derived peptides; heparin-binding domains; heparin; heparan sulfate; DNA fragments; and DNA plasmids. If other such substances have therapeutic value in the orthopaedic field, it is anticipated that at least some of these
  • Bioly derived agents include one or more of the following: bone (autograft, allograft, and xenograft) and derivates of bone; cartilage (autograft, allograft, and xenograft), including, for example, meniscal tissue, and derivatives; ligament (autograft, allograft, and xenograft) and derivatives; derivatives of intestinal tissue (autograft, allograft, and xenograft), including for example submucosa; derivatives of stomach tissue (autograft, allograft, and xenograft), including for example submucosa; derivatives of bladder tissue (autograft, allograft, and xenograft), including for example submucosa; derivatives of alimentary tissue (autograft, allograft, and xenograft), including for example submucosa; derivatives of respiratory tissue (autograft, allograft, and xenograft), including for
  • biologically derived agents Purified ECM and other collagen sources are also intended to be included within “biologically derived agents.” If other such substances have therapeutic value in the orthopaedic field, it is anticipated that at least some of these substances will have use in the present invention, and such substances should be included in the meaning of “biologically-derived agent” and “biologically-derived agents” unless expressly limited otherwise.
  • Bioremodelable collageneous tissue matrices also include bioremodelable collageneous tissue matrices.
  • the expressions “bioremodelable collagenous tissue matrix” and “naturally occurring bioremodelable collageneous tissue matrix” include matrices derived from native tissue selected from the group consisting of skin, artery, vein, pericardium, heart valve, dura mater, ligament, bone, cartilage, bladder, liver, stomach, fascia and intestine, tendon, whatever the source.
  • bioremodelable collageneous tissue matrix is intended to refer to matrix material that has been cleaned, processed, sterilized, and optionally crosslinked, it is not within the definition of a naturally occurring bioremodelable collageneous tissue matrix to purify the natural fibers and reform a matrix material from purified natural fibers.
  • bioremodelable collageneous tissue matrices includes “extracellular matrices” within its definition.
  • Cells include one or more of the following: chondrocytes; fibrochondrocytes; osteocytes; osteoblasts; osteoclasts; synoviocytes; bone marrow cells; mesenchymal cells; stromal cells; stem cells; embryonic stem cells; precursor cells derived from adipose tissue; peripheral blood progenitor cells; stem cells isolated from adult tissue; genetically transformed cells; a combination of chondrocytes and other cells; a combination of osteocytes and other cells; a combination of synoviocytes and other cells; a combination of bone marrow cells and other cells; a combination of mesenchymal cells and other cells; a combination of stromal cells and other cells; a combination of stem cells and other cells; a combination of embryonic stem cells and other cells; a combination of precursor cells isolated from adult tissue and other cells; a combination of peripheral blood progenitor cells and other cells; a combination of stem cells isolated from adult tissue and other cells; and
  • a sterilized implant may be subsequently seeded with living cells and packaged in an appropriate medium for the cell type used.
  • a cell culture medium comprising Dulbecco's Modified Eagles Medium (DMEM) can be used with standard additives such as non-essential amino acids, glucose, ascorbic acid, sodium pyruvate, fungicides, antibiotics, etc., in concentrations deemed appropriate for cell type, shipping conditions, etc.
  • DMEM Dulbecco's Modified Eagles Medium
  • Biocompatible inorganic materials include materials such as hydroxyapatite, all calcium phosphates, alpha-tricalcium phosphate, beta-tricalcium phosphate, calcium carbonate, barium carbonate, calcium sulfate, barium sulfate, polymorphs of calcium phosphate, sintered and non-sintered ceramic particles, and combinations of such materials. If other such substances have therapeutic value in the orthopaedic field, it is anticipated that at least some of these substances will have use in the present invention, and such substances should be included in the meaning of “biocompatible inorganic material” and “biocompatible inorganic materials” unless expressly limited otherwise.
  • bioactive agents biologically derived agents, cells, biological lubricants, biocompatible inorganic materials, biocompatible polymers can be used with the scaffolds and methods of the present invention.
  • a defect in goat articular cartilage was repaired with a device as illustrated in FIG. 11.
  • HA was applied post-operatively after repairing the defect with a synthetic scaffold according to FIG. 11.
  • the tissue repaired with both the device and HA appeared to be more mature, with a whiter, more hyaline-like appearance.
  • the repaired tissue that is treated with both the device and HA showed evidence of less severe degradative changes than is seen in the non-HA treated animals.
  • HA biological lubricant
  • GAG sulfates e.g. chondroitin sulfate
  • biological lubricants it will be desirable to provide the biological lubricant in a fluidized form to maximize lubrication.
  • different materials identified as falling within the definition of biological lubricants can be expected to have different efficacies as lubricants and different biological efficacies.
  • those sharing properties (e.g. viscosity) similar to those of HA may provide greater clinical benefit as lubricants.
  • those decreasing the coefficient of friction between the implant and healthy cartilage, compared to the case without the lubricant are expected to be beneficial, and particularly those biological lubricants providing a reduced coefficient of friction for an extended period time.
  • Other of the identified biological lubricants may provide greater clinical benefit as biologic agents.

Abstract

A method for the repair of a cartilaginous tissue defect, a cartilage repair device and a method of making a cartilage repair device are disclosed. In the method for the repair of a cartilaginous tissue defect, a device comprising a synthetic polymer is implanted into the defect, and a biological lubricant is administered to the defect. The device comprises a synthetic polymer and a biological lubricant.

Description

  • This application claims priority to U.S. Provisional Application No. 60/388,724, filed Jun. 14, 2002, and U.S. Provisional Application No. 60/305,786, filed Jul. 16, 2001, hereby incorporated by reference.[0001]
  • CROSS REFERENCE
  • Cross reference is made to copending U.S. patent applications Ser. No. ______ entitled “Meniscus Regeneration Device and Method” (Attorney Docket No. 265280-71141, DEP-745); Ser. No. ______ entitled “Devices from Naturally Occurring Biologically Derived Materials” (Attorney Docket No. 265280-71142, DEP-748); Ser. No. ______ entitled “Cartilage Repair Apparatus and Method” (Attorney Docket No. 265280-71143, DEP-749); Ser. No. ______ entitled “Unitary Surgical Device and Method” (Attorney Docket No. DEP-750); Ser. No. ______ entitled “Hybrid Biologic/Synthetic Porous Extracellular Matrix Scaffolds” (Attorney Docket No. 265280-71144, DEP-751); Ser. No. ______ entitled “Cartilage Repair and Regeneration Device and Method” (Attorney Docket No. 265280-71145, DEP-752); Ser. No. ______ entitled “Porous Extracellular Matrix Scaffold and Method” (Attorney Docket No. 265280-71146, DEP-747); and Ser. No. ______ entitled “Porous Delivery Scaffold and Method” (Attorney Docket No. 265280-71207, DEP-762), each of which is assigned to the same assignee as the present application, each of which is filed concurrently herewith, and each of which is hereby incorporated by reference. Cross reference is also made to U.S. patent application Ser. No. 10/172,347 entitled “Hybrid Biologic-Synthetic Bioabsorbable Scaffolds” which was filed on Jun. 14, 2002, which is assigned to the same assignee as the present application, and which is hereby incorporated by reference. [0002]
  • BACKGROUND OF THE INVENTION
  • Articular cartilage is a type of hyaline cartilage that lines the surfaces of the opposing bones in a diarthrodial joint (e.g. knee, hip, shoulder, etc.). Articular cartilage provides a near-frictionless articulation between the bones, while also functioning to absorb and transmit the compressive and shear forces encountered in the joint. Further, since the tissue associated with articular cartilage is aneural, these load absorbing and transmitting functions occur in a painless fashion in a healthy joint. [0003]
  • Fibrocartilage is found in diarthrodial joints, symphyseal joints, intervertebral discs, articular discs, as inclusions in certain tendons that wrap around a pulley, and at insertion sites of ligaments and tendons into bone. Made of a mixture of collagen type I and type II fibers, fibrocartilage can also be damaged, causing pain in the affected joint. It is understood for purposes of this application that the term “cartilage” includes articular cartilage and fibrocartilage. [0004]
  • When cartilage tissue is no longer healthy it can cause debilitating pain in the joint. For example, articular cartilage health can be affected by disease, aging, or trauma, all of which primarily involve a breakdown of the matrix consisting of a dense network of proteoglycan aggregates, collagen fibers, and other smaller matrix proteins. Tissue cells are unable to induce an adequate healing response because they are unable to migrate, being enclosed in lacunae surrounded by a dense matrix. Further, since the tissue is avascular, initiation of healing by circulating cells is limited. Similarly, damage or degeneration of knee fibrocartilage i.e. the menisci, is a common occurrence. A damaged or degenerated meniscus has little ability to heal or repair itself because the pathology frequently occurs in the avascular part of the tissue. [0005]
  • Several articular cartilage repair strategies have been attempted in the past. These include surgical techniques such as microfracturing or performing abrasion arthroplasty on the bone bed to gain vascular access, and hence, stimulate extrinsic repair in the defective region. The long-term outcome of these techniques, however, has been known to result in mechanically inferior fibrocartilagenous tissue. [0006]
  • Another surgical technique is mosaicplasty or osteochondral autograft transfer system (OATS). In this case, cylindrical plugs of healthy articular cartilage from a low-load bearing region of the knee are taken and transplanted into the defective region. This technique, however, can result in excessive donor-site morbidity and associated pain. Additionally, surgeons have reported that the gaps between the round transplants are frequently filled with fibrocartilage which can eventually erode away, thus potentially compromising the integrity of repair throughout the affected area. [0007]
  • The only FDA-approved cartilage treatment product in the market involves autologous chondrocyte implantation (CartiCel™). Autologous chondrocyte implantation involves performing an initial biopsy of healthy cartilage from the patient, isolating the cells from the tissue, expanding the cells in vitro by passaging them in culture, and then reintroducing the cells into the defective area. The cells are retained within the defect by applying a periosteal tissue patch over the defect, suturing the edges of the patch to the host tissue, and then sealing with fibrin glue. The efficacy of this expensive procedure, however, has recently been put into question by studies that have shown that only a few of the injected cells are retained within the defect and that they may not significantly contribute to the repair process. The healing observed is similar to that observed with microfracture or abrasion of the bone bed, suggesting that it is the preparation of the bone bed and not the introduction of the cells that facilitates the healing process. [0008]
  • Tissue engineering strategies for healing cartilage are being investigated by several academic and commercial teams and show some promise. One approach primarily involves using a biocompatible biologic or synthetic scaffold to deliver cells or stimulants to the defect site. The scaffold material can be a purified biologic polymer in the form of a porous scaffold or a gel (purified collagens, glycoproteins, proteoglycans, polysaccharides, or the like in various combinations) or porous scaffolds of synthetic biodegradable polymers (PLA, PGA, PDS, PCL, or the like, in various combinations). Several challenges remain with this approach, however. Some of these challenges include retention of the active stimulant at the defect site, inability to control the rate of release of the stimulant (resulting in tissue necrosis due to overdose), and cytotoxicity of the cells due to the degradation by-products of the synthetic polymers. [0009]
  • In another technique, various collagen scaffolds have been used to provide a scaffold for repair and regeneration of damaged cartilage tissue. U.S. Pat. No. 6,042,610 to ReGen Biologics, hereby incorporated by reference, discloses the use of a device to regenerate meniscal fibrocartilage. The disclosed device comprises a bioabsorbable material made at least in part from purified collagen and glycosaminoglycans (GAG). Purified collagen and glycosaminoglycans are co-lyophilized to create a foam and then cross-linked to form the device. The device can be used to provide augmentation for a damaged meniscus. Related U.S. Pat. Nos. 5,735,903, 5,479,033, 5,306,311, 5,007,934, and 4,880,429 also disclose a meniscal augmentation device for establishing a scaffold adapted for ingrowth of meniscal fibrochondrocyts. [0010]
  • It is also known to use naturally occurring extracellular matrices (ECMs) to provide a scaffold for tissue repair and regeneration. One such ECM is small intestine submucosa (SIS). SIS has been described as a natural biomaterial used to repair, support, and stabilize a wide variety of anatomical defects and traumatic injuries. See, for example, Cook® Online New Release provided by Cook Biotech at “www.cookgroup.com”. The SIS material is reported to be a naturally-occurring collagenous matrix derived from porcine small intestinal submucosa that models the qualities of its host when implanted in human soft tissues. Further, it is taught that the SIS material provides a natural matrix with a three-dimensional structure and biochemical composition that attracts host cells and supports tissue remodeling. SIS products, such as Oasis material and Surgisis material, are commercially available from Cook Biotech, Bloomington, Ind. [0011]
  • An SIS product referred to as RESTORE Orthobiologic Implant is available from DePuy Orthopaedics, Inc. in Warsaw, Ind. The DePuy product is described for use during rotator cuff surgery, and is provided as a resorbable framework that allows the rotator cuff tendon to regenerate itself. The RESTORE Implant is derived from porcine small intestine submucosa that has been cleaned, disinfected, and sterilized. Small intestine submucosa (SIS) has been described as a naturally-occurring ECM composed primarily of collagenous proteins. Other biological molecules, such as growth factors, glycosaminoglycans, etc., have also been identified in SIS. See Hodde et al., Tissue Eng. 2(3): 209-217 (1996); Voytik-Harbin et al., J. Cell Biochem., 67:478-491 (1997); McPherson and Badylak, Tissue Eng., 4(1): 75-83 (1998); Hodde et al., Endothelium, 8(1):11-24 (2001); Hodde and Hiles, Wounds, 13(5): 195-201 (2001); Hurst and Bonner, J. Biomater. Sci. Polym. Ed., 12(11) 1267-1279 (2001); Hodde et al., Biomaterial, 23(8): 1841-1848 (2002); and Hodde, Tissue Eng., 8(2): 295-308 (2002), all of which are incorporated by reference herein. During seven years of preclinical testing in animals, there were no incidences of infection transmission form the implant to the host, and the RESTORE Implant has not decreased the systemic activity of the immune system. See Allman et al., Transplant, 17(11): 1631-1640 (2001); Allman et al., Tissue Eng., 8(1): 53-62 (2002). [0012]
  • While small intestine submucosa is available, other sources of submucosa are known to be effective for tissue remodeling. These sources include, but are not limited to, stomach, bladder, alimentary, respiratory, or genital submucosa, or liver basement membrane. See, e.g., U.S. Pat. Nos. 6,171,344, 6,099,567, and 5,554,389, hereby incorporated by reference. Further, while SIS is most often porcine derived, it is known that these various submucosa materials may be derived from non-porcine sources, including bovine and ovine sources. Additionally, other collagenous matrices are known, for example lamina propria and stratum compactum. [0013]
  • It is also known to promote cartilage growth using glycosaminoglycans (GAG), such as hyaluronic acid (HA), dermatan sulfate, heparan sulfate, chondroiton sulfates, keratin sulfate, etc. See, e.g., U.S. Pat. Nos. 6,251,876 and 6,288,043, hereby incorporated by reference. GAGs are naturally found mostly in the extracellular matrix and on the cell surface as proteoglycans. These macromolecules are secreted by cells and play a role in both signal transduction and storage of some growth factors. In addition to the biological functions, the viscoelastic properties of GAGs provide a mechanical function by providing lubrication within a joint, to decrease friction. Hyaluronic acid is a natural component of the extracellular matrix of most cartilage tissues. HA is a linear polymer made up of repeating GAG disaccharide units of D-glucuronic acid and N-acetylglycosamine in β(1-3) and β(1-4) linkages. Illustratively HA can have a molecular weight ranging from about 300,000 kDa to about 6,000,000 kDa and can be uncrosslinked, naturally crosslinked, or crosslinked using mechanical, chemical, or enzymatic methods. The effect of treating extrasynovial tendons with HA and chemically modified HA has also been studied with reference to tendon gliding resistance and tendon adhesions to surrounding tissue after repair. Momose, Amadio, Sun, Chunfeng Zhao, Zobitz, Harrington and An, “Surface Modification of Extrasynovial Tendon by Chemically Modified Hyaluronic Acid Coating,” J. Biomed. Mater. Res. 59: 219-224 (2002). [0014]
  • SUMMARY OF THE INVENTION
  • It has been found that the combination of a biocompatible scaffold and HA produces a synergistic effect. Healing rates and/or quality of healing is better than the healing expected from additive effects of the scaffold or HA alone. Moreover, it has been found that retention of HA at the defect site is not problematic and co-administration of the scaffold and HA does not require HA to be cross-linked to the scaffold material. Thus, the present invention provides methods for the repair of damaged or diseased cartilaginous tissue, wherein a biocompatible scaffold and HA are co-administered to the cartilaginous tissue defect. [0015]
  • In addition to HA, GAGs such as dermatan sulfate, heparan sulfate, chondroitin sulfate, and keratan sulfate are also expected to be usable with the present invention. As used herein, “biological lubricant” is used to identify the aforementioned materials and others such as synovial fluid and components thereof, including mucinous glycoproteins (for example lubricin), tribonectins, articular cartilage superficial zone proteins, surface-active phospholipids, and lubricating glycoproteins I, II; vitronectin; and rooster comb hyaluronate (e.g. commercially available HEALON®, (Pharmacia Corporation, Peapack, N.J.), for example, and mixtures thereof. Such materials serve both a biological and a mechanical function: they play a biological role in directly and indirectly influencing cellular behavior by being involved in signal transduction alone or in conjunction with other extracellular matrix components such as growth factors, glycoproteins, collagens etc., and a mechanical role in providing lubrication. Thus, the use of the expression “biological lubricant” is intended to encompass materials that provide some biological function (influencing cellular behavior) and some mechanical function (lubrication). [0016]
  • It is believed that some commercially-available biological lubricants can be used in the practice of the present invention. Examples of such commercially-available lubricants include: ARTHREASE™ high molecular weight sodium hyaluronate, available in Europe from DePuy Orthopaedics, Inc. of Warsaw, Ind.; SYNVISC® Hylan G-F 20, manufactured by Biomatrix, Inc., of Ridgefield, N.J. and distributed by Wyeth-Ayerst Pharmaceuticals of Philadelphia, Pa.; and HYLAGAN® sodium hyaluronate, available from Sanofi-Synthelabo, Inc., of New York, N.Y. The expressions “HA”, “GAG”, and “biological lubricant” are intended to encompass these materials. It should be understood that there may be other salts of hyaluronic acid that may be used in the present invention, and the expressions “HA”, “GAG”, and “biological lubricant” should be understood to encompass such salts. [0017]
  • The three-dimensional biologic or synthetic scaffolds may be provided in the form of a fibrous nonwoven or foam material. The scaffold preferably has interconnecting pores or voids to facilitate the transport of nutrients and/or invasion of cells into the scaffold. The interconnected voids range in size, for example, from about 20 to 400 microns, illustratively 50 to 250 microns, depending on the application. The range of the void size in the construct can be manipulated by changing process steps during construct fabrication. See Ser. No. ______ entitled “Porous Delivery Scaffold and Method” (Attorney Docket No. 265280-71207, DEP-762), already incorporated by reference. The foam optionally may be formed around a reinforcing material, for example, a knitted mesh or an ECM layer. See U.S. patent application Ser. No. 10/172,347 entitled “Hybrid Biologic-Synthetic Bioabsorbable Scaffolds” which was filed on Jun. 14, 2002, already incorporated by reference. The fibers used to make the scaffold can be made of any biocompatible material, including bioabsorbable materials such as polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyvinyl alcohol (PVA), copolymers or blends thereof, or combinations of synthetic and biologic polymers. See also, Ser. No. ______ entitled “Hybrid Biologic/Synthetic Porous Extracellular Matrix Scaffolds” (Attorney Docket No. 265280-71144, DEP-751). The biologic polymers may comprise ECM, particularly comminuted ECM. In an exemplary embodiment, the fibers that comprise scaffold are formed of a polylactic acid and polyglycolic acid copolymer at a 95:5 mole ratio. [0018]
  • In one embodiment of the present invention, a method is provided wherein the scaffold material is implanted into the defect. The biological lubricant, which can be a GAG or HA for example, is administered separately, either at the time of surgery or via injection subsequent to closure of the incision. Optionally, a series of additional injections may be administered over a period of time. In either case, the injection may be made intra-articularly. [0019]
  • In another embodiment, a method is provided wherein the scaffold material and the biological lubricant are administered to the defect together. The scaffold material may be saturated with the biological lubricant at the time of surgery. Alternatively, the scaffold material may be saturated with the biological lubricant at the time of manufacture, and may be packaged together. Optionally, a series of additional injections may be administered in this method as well. [0020]
  • In still another embodiment, an implantable device is provided comprising a scaffold material saturated with a biological lubricant.[0021]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a diagrammatical view showing a tibial platform with a typical meniscus structure on the platform and a portion of the meniscus removed for illustration purposes, the tibia platform being below the condyles of the femur; [0022]
  • FIG. 2 is a view looking down at the tibial platform and showing diagrammatically the insertion of a scaffold to replace the portion of the meniscus removed; [0023]
  • FIG. 3 shows the inserted scaffold in a position to be attached to the portions of the meniscus remaining after the injured portion is removed; [0024]
  • FIG. 4 is a sectional view taken from FIG. 3 along the lines [0025] 4-4;
  • FIG. 5 is a perspective view showing an open wedge-shaped device comprising an upper panel and a lower panel angularly separated to define an apex portion and a base portion; [0026]
  • FIG. 6 shows a wedge shaped device prior to folding with a pocket shown in imaginary lines formed in the device; [0027]
  • FIG. 7 shows a further step in the process in making the device shown in FIG. 6 to produce a filled, wedge-shaped device; [0028]
  • FIG. 8 is a top view of a ECM device used for the repair of a meniscal defect and having barbs for attachment; [0029]
  • FIG. 9 is a top view of a device similar to that shown in FIG. 1, except having sutures for attachment; [0030]
  • FIG. 10 is a perspective, partially cut-away view of a meniscus with the device of FIG. 1 inserted into the meniscus; [0031]
  • FIG. 11 is a cross sectional view of a cartilage repair device implanted in subchondral bone, note that the anchor is shown in elevation rather than cross section for clarity of description; and [0032]
  • FIG. 12 is a cross sectional view of a cartilage repair device which uses an alternative embodiment of an anchor.[0033]
  • DETAILED DESCRIPTION
  • While the invention is susceptible to various modifications and alternative forms, specific embodiments thereof have been shown by way of example in the drawings and will herein be described in detail. It should be understood, however, that there is no intent to limit the invention to the particular forms disclosed, but on the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the appended claims. [0034]
  • Referring to FIG. 1, it will be seen that a [0035] tibial platform 10 below the condyles 12 of a knee support a meniscus 11 from which an illustrative defective portion 14 is removed to leave a wedge-shaped space 16. In the removal process, the surgeon will often leave an outer rim 18 of the meniscus. The meniscus provides a large surface of articulation between the otherwise incongruent surfaces of the tibia platform or plateau and the femur condyles (such indicated at 12). The meniscus serves to reduce contact stresses and wear in the knee joint.
  • The [0036] portion 14 removed from the structure shown in FIG. 1 includes a portion of the original meniscus which was within the avascular zone, particularly the radially inner portion, and may include a portion of the original meniscus which was within the vascular zone.
  • FIG. 2 shows how a [0037] scaffold device 20 may illustratively be inserted into the space 16 to be against the outer rim 18. This illustrative scaffold 20 is shown in FIGS. 3 and 4 in position filling the space 16 and against the rim 18 left by the surgeon. FIG. 4 shows the scaffold as comprising an upper cover or upper panel 22 and a lower cover or lower panel 24. These panels 22, 24, which may illustratively be angularly related, will define an internal space 26 between the covers. Internal space 26 optionally may be filled with a biological material, a biological structure, or a synthetic structure providing a framework for regeneration of the meniscus into the space 16. Illustratively, panels 22, 24 may be made from woven or nonwoven mats of synthetic polymer or synthetic/biologic polymers. Alternatively, scaffold 20 may be constructed by forming the synthetic or synthetic/biologic polymers in a mold, or by sculpting a block of the polymer into the proper shape.
  • The scaffolds may comprise synthetic polymers such as polylactic acid (PLA), polyglocolic acid (PGA), polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyvinyl alcohol (PVA), and copolymers and blends thereof. The synthetic polymers may be provided as textiles with woven, knitted, warped knitted, nonwoven, braided, and foamed structures, and illustratively may be imbedded in ECM material, as in copending U.S. patent application Ser. No. 10/172,347 entitled “Hybrid Biologic-Synthetic Bioabsorbable Scaffolds” which was filed on Jun. 14, 2002, or may be provided as foams with or without ECM materials, as in copending U.S. patent application Ser. No. ______ entitled “Hybrid Biologic/Synthetic Porous Extracellular Matrix Scaffolds” (Attorney Docket No. 265280-71144, DEP-751). Thus, the scaffold may be made of biocompatible polymers, with or without a biologic component, and may be provided in a variety of woven, knitted, nonwoven, braided formed, or molded, or other configurations. [0038]
  • [0039] Scaffold 20 may be inserted, for example, in arthroscopic surgery through portals provided in the outer anterior surface of the knee opening into the knee cavity between the condyles 12 and the tibial platform 10. However, any surgical procedure to insert a device into damaged cartilage is within the scope of the present invention. Illustratively, the upper cover 22 of the scaffold 20 may serve as a bearing surface for the condyle 12 disposed thereabove and be subjected to the compression and stress forces involved in articulation of the knee. The condyle will move upon the upper surface of the cover 22.
  • Turning to FIGS. 5, 6 and [0040] 7, it will be seen that an illustrative device is somewhat diagrammatically illustrated. The illustrative device 30 includes an upper panel 32 and a lower panel 34 defining a wedge-shaped device having a base portion 36 and an apex portion 38. FIG. 6 suggests that the device may include a formed wedge-shaped cavity 39 (illustrated in phantom) and that the device may be folded about a fold line 40 to provide a device such as indicated at 42 in FIG. 7. While the FIG. 5 device 30 suggests an open wedge-shaped design, the device 42 in FIG. 7 suggests that, between the upper and lower panels 32, 34 a mass of biological material may be disposed. In FIG. 6, a plurality of tacks 44 are shown attached to one of the two panels of the device to be used for securing the device to surrounding tissue in the knee. The panels 32, 34 may be trimmed to the desired wedge shape.
  • Referring now to FIGS. [0041] 8-10, there are shown scaffolds similar to those shown in FIGS. 6-7, except that device 100 need not be wedge shaped. Scaffold 100 comprises panels 102 and 104, with a pillow 106 of biological or synthetic material shaped to fill the void in meniscus 111 left after a partial menisectomy, as illustrated in FIG. 1. The pillow is placed between panels 102 and 104. In the illustrative embodiment, pillow 106 is smaller than panels 102 and 104, and wing portions 105 of panels 102 and 104 extend beyond pillow 106.
  • As shown in FIG. 8, [0042] scaffold 100 may be provided with barbed darts 112 extending from wings 105. A needle or similar device would be used to push the barbed darts 112 into or through the meniscus to secure scaffold 100 to the meniscus. Barbed darts may be made of any biocompatible material sufficiently rigid to secure scaffold 100 to the meniscus. Barbed darts 112 may be provided integrally with scaffold 100 or may be added by the surgeon prior to insertion of the device.
  • The [0043] scaffold 100 illustrated in FIG. 9 is similar to the scaffold shown in FIG. 8, except that instead of barbed darts, the scaffold of FIG. 9 is provided with sutures 113. The scaffold of FIG. 9 may be affixed to the meniscus in a manner similar to that of the scaffold of FIG. 8. A needle or similar device would be used to push the sutures 113 through the meniscus. As illustrated in FIG. 10, the sutures may be tied together on the outside of the meniscus to form knots 120 that secure scaffold 100 in place.
  • While in the various embodiments discussed herein, tacks and sutures have been shown for anchoring the devices, it will be appreciated that the devices may be anchored by any other method at the choice of the surgeon. [0044]
  • FIGS. 11 and 12 illustrate several scaffolds that can be used in conjunction with a biological lubricant for cartilage repair. Referring now to FIG. 11, a [0045] cartilage repair device 210 is provided for repairing damaged or diseased cartilage. The device 210 includes an anchor 212 which is anchored or otherwise positioned in an opening formed in both a section of native cartilage 216 and the underlying subchondral bone 218. The anchor 212 is configured to be secured in an area from which damaged, diseased, or destroyed native cartilage and possibly bone have been removed. The anchor 212 includes an elongated central body portion 220 and a head portion 222. The body portion 220 extends downwardly from a lower surface of the head portion 222. As shown in FIG. 11, the body portion 220 may have a number of barbs 224 extending therefrom for engaging the sidewalls of the opening formed in the bone 218. In the illustrative embodiment described herein, the barbs 224 extend radially outwardly and are inclined slightly toward the head portion 222 of the anchor 212.
  • The [0046] cartilage repair device 210 also includes a plug 226. The plug 226 is secured to the anchor 212. Specifically, the plug 226 is secured to the upper surface of the head portion 222 of the anchor 212. The plug 226 allows for communication across the removed portion (i.e., the portion of the native cartilage 216 from which the damaged or diseased cartilage has been removed) and the adjacent healthy cartilage. As such, the plug 226 functions as a chondrogenic growth-supporting matrix for promoting a positive cellular response in an effort to achieve articular cartilage regeneration.
  • The [0047] anchor 212 of the cartilage repair device 210 may be constructed of numerous types of synthetic or naturally occurring materials. For example, the anchor 212 may be constructed with a bioabsorbable polymer. Examples of such polymers include: polyesters of [alpha]-hydroxycarboxylic acids, such as poly(L-lactide) (PLLA), polyglycolide (PGA); poly-p-dioxanone (PDS); polycaprolactone (PCL); and any other bioresorbable and biocompatible polymer, co-polymer or mixture of polymers or co-polymers that are commonly used in the construction of prosthetic implants. Moreover, the anchor 212 may be constructed with a naturally occurring material such as a naturally occurring ECM (e.g., SIS). In such a case, the head portion 222 and body portion 220 of the anchor 212 may be configured as monolithic structures formed from naturally occurring ECM which is cured to be rigid and hardened to facilitate attachment to the bone 218. As such, it should be appreciated that the ECM material from which the anchor 212 is fabricated is cured to produce a structure which possesses the necessary hardness and toughness to allow the anchor 212 to be driven into bone tissue (i.e., the subchondral bone 218). See U.S. patent application Ser. No. ______ entitled “Devices from Naturally Occurring Biologically Derived Materials” (Attorney Docket No. 265280-71142, DEP-748), already incorporated by reference. It should be understood that the material selected for the anchor 212 may also comprise mixtures or composites of materials. For example, the anchor 212 could comprise both a polymer and ECM material.
  • As mentioned above, the [0048] plug 226, which is fixed to the anchor 212, functions as a chondrogenic growth-supporting matrix for promoting vascular invasion and cellular proliferation in an effort to achieve articular cartilage regeneration. A central body 230 of the plug 226 is configured as a porous structure of biodegradable material. When anchored to a defective area of cartilage, cells can migrate into and proliferate within the plug 226, biodegrade the plug 226 while, at the same time, synthesize new and healthy tissue to heal the defective area. The plug 226 may be made out of a nonwoven or foam scaffold of synthetic or synthetic/biologic fibers with the desired porosity and material density. Specifically, the material density and/or porosity of the plug 226 may be varied to control cell migration and proliferation. The cells can migrate from adjacent tissue or from synovial fluid. The fibers from which the plug 226 is constructed also may be formed to have a structural rigidity sufficient to withstand the compression and shear stress to which the cartilage 216 is subjected. As such, the porous material from which the plug 226 is constructed should have the structural rigidity necessary to bear the forces associated with the other bone.
  • One particularly useful material for fabricating the [0049] plug 226 is a porous scaffold or “foam” composed of synthetic fibers or a combination of synthetic fibers and naturally occurring ECM. Both the material density and the pore size of the foam plug 226 may be varied to fit the needs of a given plug design. Such foams may be fabricated by lyophilizing (i.e., freeze-drying) the fibers suspended in water. The material density and pore size of the resultant foam may be varied by controlling, among other things, the rate of freezing of the fiber suspension and/or the amount of water or moisture content in the fiber suspension at the on-set of the freezing process. See U.S. patent application Ser. No. ______ entitled “Cartilage Repair Apparatus and Method” (Attorney Docket 265280-71143, DEP-7490 and Ser. No. ______ entitled “Porous Extracellular Matrix Scaffold and Method” (Attorney Docket 265280-71146, DEP-747), already incorporated by reference.
  • Referring now to FIG. 12, there is shown another embodiment of a cartilage repair device (hereinafter referred to with reference numeral [0050] 410). The cartilage repair device 410 is somewhat similar to the cartilage repair device 210. As such, the same reference numerals are used in FIG. 12 to identify components which have previously been discussed, with additional discussion thereof being unwarranted. The cartilage repair device 410 includes an anchor 412 which is used in lieu of the anchor 212 described in regard to FIG. 11. In particular, in the embodiment shown in FIG. 12, the plug 226 is positioned in an osteochondral defect 414 without the use of a bottom-mounted anchor (i.e., the anchor 212 of FIG. 11). Similarly to as described above, the plug 226 is constructed out of synthetic fibers or a combination of synthetic fibers and naturally occurring ECM (e.g., SIS) having a desired porosity and material density.
  • The [0051] plug 226 is retained in the hole formed in the cartilage 216 and protected from in vivo forces by an annular shaped anchor 412. The anchor 412 may be provided in many different configurations which allow it to be press fit or otherwise anchored into the subchondral bone 218. For example, as shown in FIG. 12, the anchor 412 may be “bottle cap”-shaped so as to allow the anchor 412 to be press fit or otherwise secured into an annular groove 416 formed in the subchondral bone 218. The groove may be formed and the anchor may be shaped as described and shown in Patent Cooperation Treaty publication WO 01/39694 A2, published Jun. 7, 2001 entitled “Fixation Technology”, the complete disclosure of which is incorporated by reference herein. Alternatively, the anchor 412 may be mechanically secured to the subchondral bone 218 by use of adhesive or other types of anchoring structures (e.g., barbs).
  • The [0052] anchor 412 of the cartilage repair device 410 may be constructed from numerous types of synthetic or naturally occurring materials. For example, the anchor 212 may be constructed with a bioabsorbable polymer such as PLLA, PGA, PDS, PCL, or any other such bioabsorbable polymer which is commonly used in the construction of prosthetic implants. Moreover, the anchor 412 may be constructed from a naturally occurring material such as a naturally occurring ECM (e.g., SIS) that is cured or otherwise fabricated to be rigid and hardened to facilitate attachment to the bone in the same manner as described above in regard to the anchor 212 and/or the plug 226 of FIG. 11.
  • It is expected that the teachings of the present invention may also be advantageously combined with the teachings of the following U.S. patent applications filed concurrently herewith and which are incorporated by reference herein: Ser. No. ______ entitled “Devices from Naturally Occurring Biologically Derived Materials” (Attorney Docket No. 265280-71142, DEP-748); Ser. No. ______ entitled “Unitary Surgical Device and Method” (Attorney Docket No. DEP-750); and Ser. No. ______ entitled “Porous Extracellular Matrix Scaffold and Method” (Attorney Docket No. 265280-71146, DEP-747). It is expected that the materials and devices disclosed in those patent applications can be used in the present invention. [0053]
  • Similarly, it is expected that other materials may be combined with the biological lubricant or with the scaffold. For example, bioactive agents, biologically-derived agents, cells, biocompatible inorganic material and/or combinations thereof may be mixed with the scaffold material or biological lubricant. [0054]
  • “Bioactive agents” include one or more of the following: chemotactic agents; therapeutic agents (e.g. antibiotics, steroidal and non-steroidal analgesics and anti-inflammatories, anti-rejection agents such as immunosuppressants and anti-cancer drugs); various proteins (e.g. short chain peptides, bone morphogenic proteins, glycoprotein and lipoprotein); cell attachment mediators; biologically active ligands; integrin binding sequence; ligands; various growth and/or differentiation agents (e.g. epidermal growth factor, IGF-I, IGF-II, TGF-β I-III, growth and differentiation factors, vascular endothelial growth factors, fibroblast growth factors, platelet derived growth factors, insulin derived growth factor and transforming growth factors, parathyroid hormone, parathyroid hormone related peptide, bFGF; TGFβ superfamily factors; BMP-2; BMP-4; BMP-6; BMP-12; sonic hedgehog; GDF5; GDF6; GDF8; PDGF); small molecules that affect the upregulation of specific growth factors; tenascin-C; hyaluronic acid; chondroitin sulfate; fibronectin; decorin; thromboelastin; thrombin-derived peptides; heparin-binding domains; heparin; heparan sulfate; DNA fragments; and DNA plasmids. If other such substances have therapeutic value in the orthopaedic field, it is anticipated that at least some of these substances will have use in the present invention, and such substances should be included in the meaning of “bioactive agent” and “bioactive agents” unless expressly limited otherwise. [0055]
  • “Biologically derived agents” include one or more of the following: bone (autograft, allograft, and xenograft) and derivates of bone; cartilage (autograft, allograft, and xenograft), including, for example, meniscal tissue, and derivatives; ligament (autograft, allograft, and xenograft) and derivatives; derivatives of intestinal tissue (autograft, allograft, and xenograft), including for example submucosa; derivatives of stomach tissue (autograft, allograft, and xenograft), including for example submucosa; derivatives of bladder tissue (autograft, allograft, and xenograft), including for example submucosa; derivatives of alimentary tissue (autograft, allograft, and xenograft), including for example submucosa; derivatives of respiratory tissue (autograft, allograft, and xenograft), including for example submucosa; derivatives of genital tissue (autograft, allograft, and xenograft), including for example submucosa; derivatives of liver tissue (autograft, allograft, and xenograft), including for example liver basement membrane; derivatives of skin tissue; platelet rich plasma (PRP), platelet poor plasma, bone marrow aspirate, demineralized bone matrix, insulin derived growth factor, whole blood, fibrin and blood clot. Purified ECM and other collagen sources are also intended to be included within “biologically derived agents.” If other such substances have therapeutic value in the orthopaedic field, it is anticipated that at least some of these substances will have use in the present invention, and such substances should be included in the meaning of “biologically-derived agent” and “biologically-derived agents” unless expressly limited otherwise. [0056]
  • “Biologically derived agents” also include bioremodelable collageneous tissue matrices. The expressions “bioremodelable collagenous tissue matrix” and “naturally occurring bioremodelable collageneous tissue matrix” include matrices derived from native tissue selected from the group consisting of skin, artery, vein, pericardium, heart valve, dura mater, ligament, bone, cartilage, bladder, liver, stomach, fascia and intestine, tendon, whatever the source. Although “naturally occurring bioremodelable collageneous tissue matrix” is intended to refer to matrix material that has been cleaned, processed, sterilized, and optionally crosslinked, it is not within the definition of a naturally occurring bioremodelable collageneous tissue matrix to purify the natural fibers and reform a matrix material from purified natural fibers. The term “bioremodelable collageneous tissue matrices” includes “extracellular matrices” within its definition. [0057]
  • “Cells” include one or more of the following: chondrocytes; fibrochondrocytes; osteocytes; osteoblasts; osteoclasts; synoviocytes; bone marrow cells; mesenchymal cells; stromal cells; stem cells; embryonic stem cells; precursor cells derived from adipose tissue; peripheral blood progenitor cells; stem cells isolated from adult tissue; genetically transformed cells; a combination of chondrocytes and other cells; a combination of osteocytes and other cells; a combination of synoviocytes and other cells; a combination of bone marrow cells and other cells; a combination of mesenchymal cells and other cells; a combination of stromal cells and other cells; a combination of stem cells and other cells; a combination of embryonic stem cells and other cells; a combination of precursor cells isolated from adult tissue and other cells; a combination of peripheral blood progenitor cells and other cells; a combination of stem cells isolated from adult tissue and other cells; and a combination of genetically transformed cells and other cells. If other cells are found to have therapeutic value in the orthopaedic field, it is anticipated that at least some of these cells will have use in the present invention, and such cells should be included within the meaning of “cell” and “cells” unless expressly limited otherwise. Illustratively, in one example of embodiments that are to be seeded with living cells such as chondrocytes, a sterilized implant may be subsequently seeded with living cells and packaged in an appropriate medium for the cell type used. For example, a cell culture medium comprising Dulbecco's Modified Eagles Medium (DMEM) can be used with standard additives such as non-essential amino acids, glucose, ascorbic acid, sodium pyruvate, fungicides, antibiotics, etc., in concentrations deemed appropriate for cell type, shipping conditions, etc. [0058]
  • “Biocompatible inorganic materials” include materials such as hydroxyapatite, all calcium phosphates, alpha-tricalcium phosphate, beta-tricalcium phosphate, calcium carbonate, barium carbonate, calcium sulfate, barium sulfate, polymorphs of calcium phosphate, sintered and non-sintered ceramic particles, and combinations of such materials. If other such substances have therapeutic value in the orthopaedic field, it is anticipated that at least some of these substances will have use in the present invention, and such substances should be included in the meaning of “biocompatible inorganic material” and “biocompatible inorganic materials” unless expressly limited otherwise. [0059]
  • It is expected that various combinations of bioactive agents, biologically derived agents, cells, biological lubricants, biocompatible inorganic materials, biocompatible polymers can be used with the scaffolds and methods of the present invention. [0060]
  • It is expected that standard disinfection and sterilization techniques may be used with the products of the present invention. [0061]
  • EXAMPLE 1
  • A defect in goat articular cartilage was repaired with a device as illustrated in FIG. 11. HA was applied post-operatively after repairing the defect with a synthetic scaffold according to FIG. 11. When compared to cartilage defects repaired without HA, the tissue repaired with both the device and HA appeared to be more mature, with a whiter, more hyaline-like appearance. Also, the repaired tissue that is treated with both the device and HA showed evidence of less severe degradative changes than is seen in the non-HA treated animals. [0062]
  • Although the examples all relate to use of HA, it is expected that other biological lubricants will provide similar benefits. It should be understood that the nature of the biological lubricant and the means of administering the biological lubricant can affect the quality of lubrication provided and can also affect the biological effects observed. For example, although a biological lubricant such as HA can be cross-linked to the matrix and still provide adequate lubrication, some GAG sulfates (e.g. chondroitin sulfate) can be expected to be less effective, or ineffective, as a lubricant if cross-linked or co-lyophilized with the underlying matrix, yet still be used for its biological effects. For some biological lubricants, it will be desirable to provide the biological lubricant in a fluidized form to maximize lubrication. In addition, different materials identified as falling within the definition of biological lubricants can be expected to have different efficacies as lubricants and different biological efficacies. Of the identified biological lubricants, those sharing properties (e.g. viscosity) similar to those of HA may provide greater clinical benefit as lubricants. Of the identified biological lubricants, those decreasing the coefficient of friction between the implant and healthy cartilage, compared to the case without the lubricant, are expected to be beneficial, and particularly those biological lubricants providing a reduced coefficient of friction for an extended period time. Other of the identified biological lubricants may provide greater clinical benefit as biologic agents. It should also be understood that materials identified as biological lubricants and the means of administering the material may be combined in various ways to take advantage of the properties of each and to maximize the clinical benefits of administering the various materials. Although the invention has been described in detail with reference to certain preferred embodiments, variations and modifications exist within the scope and spirit of the invention as described and defined in the following claims. [0063]

Claims (51)

1. A method for the repair of a cartilagenous tissue defect comprising the steps of
implanting a scaffold into the defect, and
administering a biological lubricant to the defect, wherein the biological lubricant is not crosslinked to the scaffold.
2. The method of claim 1, wherein the implanting step and administering step take place during a single surgical procedure.
3. The method of claim 2, further comprising an additional post-operative administration of biological lubricant to the defect.
4. The method of claim 1, wherein the biological lubricant comprises a GAG.
5. The method of claim 1, wherein the biological lubricant is selected from the group consisting of: hyaluronic acid; a salt of hyaluronic acid; sodium hyaluronate; dermatan sulfate; heparan sulfate; chondroiton sulfate; keratan sulfate; synovial fluid; a component of synovial fluid; vitronectin; and rooster comb hyaluronate.
6. The method of claim 1, further comprising the step of
closing an incision site created to implant the scaffold, and
wherein the administering step is subsequent to the closing step, and the biological lubricant is administered to the defect via injection in the area of the defect.
7. The method of claim 1, wherein the defect is in the knee and the biological lubricant is administered by injection into the knee joint cavity.
8. The method of claim 1, wherein the biological lubricant is administered to the defect by saturating the scaffold with a biological lubricant solution prior to implantation.
9. The method of claim 1, wherein the scaffold is provided pre saturated with biological lubricant
10. The method of claim 2, further comprising the step of
providing a series of additional biological lubricant injections to the area of the defect subsequent to the surgical procedure.
11. The method of claim 10, wherein the defect is in the knee joint and the injections are into the knee joint cavity.
12. The method of claim 10, wherein the series of additional biological lubricant injections comprises a first additional biological lubricant injection two weeks subsequent to the surgical procedure and a second additional biological lubricant injection four weeks subsequent to the surgical procedure.
13. The method of claim 1, wherein the defect is in a meniscus and implanting step is a surgical procedure comprising
performing a partial menisectomy to create a space,
placing the scaffold into the space, and
fixing the scaffold to surrounding meniscal tissue.
14. The method of claim 1, wherein the scaffold comprises a synthetic polymer.
15. The method of claim 14, wherein the synthetic polymer has a structure selected from the group consisting of woven, knitted, warped knitted, nonwoven, braided, and foamed.
16. The method of claim 14, wherein the synthetic polymer is selected from the group consisting of PLA, PGA, PCL, PDO, TMC, PVA, copolymers thereof, and blends thereof.
17. The method of claim 14, wherein the scaffold further comprises an extracellular matrix.
18. The method of claim 1, wherein the device further comprises at least one additional substance selected from the group consisting of: a bioactive agent; a biologically derived substance; cells; and a biocompatible inorganic material.
19. A method for the repair of a cartilaginous tissue defect comprising the steps of
implanting a scaffold comprising a synthetic polymer into the defect, and
administering a GAG to the defect, wherein the GAG is not crosslinked to the scaffold.
20. The method of claim 19, wherein the GAG is not crosslinked to the scaffold.
21. The method of claim 20, wherein the implanting step and administering step take place during a single surgical procedure.
22. The method of claim 21, further comprising an additional post-operative administration of a biological lubricant to the defect.
23. The method of claim 22, wherein the biological lubricant of the additional post-operative administration comprises the GAG.
24. The method of claim 23, wherein the GAG comprises HA.
25. The method of claim 20, further comprising the step of
closing an incision site created to implant the scaffold, and
wherein the administering step is subsequent to the closing step, and the GAG is administered to the defect via injection in the area of the defect.
26. The method of claim 25, wherein the defect is in the knee and the injection is into the knee joint cavity.
27. The method of claim 20, wherein the biological lubricant is administered to the defect by saturating the scaffold with a biological lubricant solution prior to implantation.
28. The method of claim 20, wherein the scaffold is provided pre-saturated with biological lubricant.
29. The method of claim 19, further comprising a series of post-operative biological lubricant injections wherein the series of post-operative biological lubricant injections comprises a first post-operative lubricant injection two weeks subsequent to the surgical procedure and a second post-operative biological lubricant injection four weeks subsequent to the surgical procedure.
30. The method of claim 19, wherein the defect is in a meniscus and implanting step comprises
performing a partial menisectomy to create a space,
placing the scaffold into the space, and
fixing the scaffold to surrounding meniscal tissue.
31. The method of claim 19, wherein the GAG is HA.
32. The method of claim 19, wherein the GAG is crosslinked to the scaffold.
33. The method of claim 19, wherein the scaffold consists essentially of the synthetic polymer.
34. A cartilage repair device comprising a synthetic polymer scaffold and a biological lubricant applied to the polymer.
35. The cartilage repair device of claim 34, wherein the biological lubricant comprises a solution.
36. The cartilage repair device of claim 34, wherein the biological lubricant solution comprises a GAG.
37. The cartilage repair device of claim 36, wherein the biological lubricant solution comprises HA.
38. The cartilage repair device of claim 37, wherein the HA is a high molecular weight sodium hyaluronate.
39. The cartilage repair device of claim 34, wherein the device further comprises a biologic component.
40. The cartilage repair device of claim 39, wherein the biologic component comprises an ECM.
41. The cartilage repair device of claim 40, wherein the ECM matrix comprises tissue derived from a source selected from the group consisting of: vertebrate small intestine submucosa; vertebrate liver basement membrane; vertebrate bladder submucosa; vertebrate stomach submucosa; vertebrate alimentary tissue; vertebrate respiratory tissue; and vertebrate genital tissue.
42. The cartilage repair device of claim 34, further comprising an additional material selected from the group consisting of: a bioactive agent; a biologically derived substance; and cells.
43. The cartilage repair device of claim 34 wherein the synthetic polymer scaffold comprises a plug configured to be positioned in an opening formed in damaged cartilage.
44. The cartilage repair device of claim 43 wherein the plug is secured to an anchor.
45. The cartilage repair device of claim 43 further comprising an anchor configured to secure the plug in the opening.
46. A method of making a cartilage repair device comprising:
providing a scaffold;
providing a biological lubricant in liquid form; and
wetting the scaffold with the liquid biological lubricant to form a wet implant.
47. The method of claim 46, further comprising packaging the wet implant and terminally sterilizing the packaged wet implant.
48. The method of claim 46, further comprising drying the wet implant, packaging the dry implant and terminally sterilizing the packaged dry implant.
49. The method of claim 46, wherein the scaffold comprises a synthetic polymer.
50. The method of claim 49, wherein the scaffold further comprises a naturally occurring extracellular matrix.
51. The method of claim 46, further comprising incorporating into the wet implant a material selected from the group consisting of: a bioactive agent; a biologically derived substance; and cells.
US10/195,334 2001-07-16 2002-07-15 Cartilage repair and regeneration scaffold and method Abandoned US20030033021A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/195,334 US20030033021A1 (en) 2001-07-16 2002-07-15 Cartilage repair and regeneration scaffold and method

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30578601P 2001-07-16 2001-07-16
US38872402P 2002-06-14 2002-06-14
US10/195,334 US20030033021A1 (en) 2001-07-16 2002-07-15 Cartilage repair and regeneration scaffold and method

Publications (1)

Publication Number Publication Date
US20030033021A1 true US20030033021A1 (en) 2003-02-13

Family

ID=26974786

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/195,606 Expired - Fee Related US8012205B2 (en) 2001-07-16 2002-07-15 Cartilage repair and regeneration device
US10/195,334 Abandoned US20030033021A1 (en) 2001-07-16 2002-07-15 Cartilage repair and regeneration scaffold and method

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/195,606 Expired - Fee Related US8012205B2 (en) 2001-07-16 2002-07-15 Cartilage repair and regeneration device

Country Status (5)

Country Link
US (2) US8012205B2 (en)
EP (2) EP1416887A4 (en)
JP (2) JP4197157B2 (en)
AU (2) AU2002316696B2 (en)
WO (2) WO2003007787A2 (en)

Cited By (144)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030023316A1 (en) * 2000-08-04 2003-01-30 Brown Laura Jean Hybrid biologic-synthetic bioabsorable scaffolds
US20030033022A1 (en) * 2001-07-16 2003-02-13 Plouhar Pamela Lynn Cartilage repair and regeneration device and method
US20030036797A1 (en) * 2001-07-16 2003-02-20 Prasanna Malaviya Meniscus regeneration device and method
US20030044444A1 (en) * 2001-07-16 2003-03-06 Prasanna Malaviya Porous extracellular matrix scaffold and method
US20030078617A1 (en) * 2001-07-16 2003-04-24 Schwartz Herbert E. Unitary surgical device and method
US20040054417A1 (en) * 2000-04-07 2004-03-18 Renzo Soffiati Disposable articulated spacing device for surgical treatment of joints of the human body
US20040059431A1 (en) * 2000-08-04 2004-03-25 Plouhar Pamela L. Reinforced small intestinal submucosa
US20040143344A1 (en) * 2001-07-16 2004-07-22 Prasanna Malaviya Implantable tissue repair device and method
US20040166169A1 (en) * 2002-07-15 2004-08-26 Prasanna Malaviya Porous extracellular matrix scaffold and method
US20040180822A1 (en) * 2002-08-09 2004-09-16 Grafton R. Donald Method of applying hyaluronic acid to implant or graft to enhance lubricity and cellular density
US20040220574A1 (en) * 2001-07-16 2004-11-04 Pelo Mark Joseph Device from naturally occuring biologically derived materials
US20040230303A1 (en) * 2003-05-16 2004-11-18 Gomes Katherine A. Cartilage allograft plug
US20040267362A1 (en) * 2003-06-30 2004-12-30 Julia Hwang Scaffold for connective tissue repair
US20050038520A1 (en) * 2003-08-11 2005-02-17 Francois Binette Method and apparatus for resurfacing an articular surface
US20050090139A1 (en) * 2002-03-28 2005-04-28 Rowland White Contact
US20050125077A1 (en) * 2003-12-05 2005-06-09 Harmon Alexander M. Viable tissue repair implants and methods of use
US20050125073A1 (en) * 2003-12-08 2005-06-09 Orban Janine M. Implant device for cartilage regeneration in load bearing articulation regions
US20050222687A1 (en) * 2004-04-02 2005-10-06 Gordana Vunjak-Novakovic Cartilage implant assembly and method for implantation
US20050251268A1 (en) * 2003-05-16 2005-11-10 Musculoskeletal Transplant Foundation Cartilage allograft plug
US20050249771A1 (en) * 2004-05-04 2005-11-10 Prasanna Malaviya Hybrid biologic-synthetic bioabsorbable scaffolds
US20050249772A1 (en) * 2004-05-04 2005-11-10 Prasanna Malaviya Hybrid biologic-synthetic bioabsorbable scaffolds
EP1652473A1 (en) 2004-10-29 2006-05-03 DePuy Products, Inc. Implant system with sizing templates
EP1652484A1 (en) 2004-10-29 2006-05-03 DePuy Products, Inc. Instruments, kit and method for suture managment
US20060128296A1 (en) * 2004-10-29 2006-06-15 Schwan Wade E Intestine processing device and associated method
US20060135638A1 (en) * 2004-12-22 2006-06-22 Pedrozo Hugo A Method for organizing the assembly of collagen fibers and compositions formed therefrom
US20060178680A1 (en) * 2005-02-07 2006-08-10 Regen Biologics, Inc. System and method for all-inside suture fixation for implant attachment and soft tissue repair
US20060190042A1 (en) * 2004-11-05 2006-08-24 Arthrotek, Inc. Tissue repair assembly
US20060189993A1 (en) * 2004-11-09 2006-08-24 Arthrotek, Inc. Soft tissue conduit device
US20060211953A1 (en) * 2004-10-29 2006-09-21 Zannis Anthony D Coordinate instrument set
US20060210643A1 (en) * 2003-04-29 2006-09-21 Truncale Katherine A G Cartilage repair mixture containing allograft chondrocytes
US20060263335A1 (en) * 2003-03-27 2006-11-23 Regentec Ltd. Porous matrix
US20060271201A1 (en) * 2005-05-25 2006-11-30 Biomet Manufacturing Corp. Porous ceramic structure containing biologics
US20060273050A1 (en) * 2002-05-24 2006-12-07 Higgins Joel C Apparatus and method for separating and concentrating fluids containing multiple components
US20070034579A1 (en) * 2002-05-03 2007-02-15 Randel Dorian Methods and apparatus for isolating platelets from blood
US20070162055A1 (en) * 1999-07-23 2007-07-12 Bowman Steven M Graft fixation device combination
US20070276191A1 (en) * 2006-05-26 2007-11-29 Sean Selover Illuminated surgical access system including a surgical access device and integrated light emitter
US20080071385A1 (en) * 2003-11-26 2008-03-20 Depuy Mitek, Inc. Conformable tissue repair implant capable of injection delivery
US20080082128A1 (en) * 2006-09-29 2008-04-03 Arthrotek, Inc. Method and apparatus for forming a self-locking adjustable suture loop
US20080125863A1 (en) * 2006-11-28 2008-05-29 Mckay William F Implant designs and methods of improving cartilage repair
US20080140094A1 (en) * 2006-12-11 2008-06-12 Schwartz Herbert E Unitary surgical device and method
US20080217264A1 (en) * 2002-05-24 2008-09-11 Biomet Manufacturing Corp. Apparatus And Method For Separating And Concentrating Fluids Containing Multiple Components
US20080255676A1 (en) * 2007-01-24 2008-10-16 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US20080269762A1 (en) * 2007-04-25 2008-10-30 Biomet Manufacturing Corp. Method and device for repair of cartilage defects
US20080274157A1 (en) * 2003-04-29 2008-11-06 Gordana Vunjak-Novakovic Cartilage implant plug with fibrin glue and method for implantation
US20080283474A1 (en) * 2007-04-12 2008-11-20 Biomet Biologics, Llc Buoy suspension fractionation system
US20090149893A1 (en) * 2007-12-05 2009-06-11 Semler Eric J Cancellous Bone Implant for Cartilage Repair
US20090221075A1 (en) * 2008-02-29 2009-09-03 Biomet Manufacturing Corp. System And Process For Separating A Material
US20090291112A1 (en) * 2003-05-16 2009-11-26 Truncale Katherine G Allograft osteochondral plug combined with cartilage particle mixture
US20090319045A1 (en) * 2004-10-12 2009-12-24 Truncale Katherine G Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US20100015202A1 (en) * 2007-03-06 2010-01-21 Semler Eric J Cancellous construct with support ring for repair of osteochondral defects
US7749250B2 (en) 2006-02-03 2010-07-06 Biomet Sports Medicine, Llc Soft tissue repair assembly and associated method
US20100222882A1 (en) * 2009-02-27 2010-09-02 Badylak Stephen F Joint bioscaffolds
US20100256595A1 (en) * 2009-04-03 2010-10-07 Biomet Biologics, Llc All-In-One Means Of Separating Blood Components
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
US7824701B2 (en) 2002-10-18 2010-11-02 Ethicon, Inc. Biocompatible scaffold for ligament or tendon repair
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7857830B2 (en) 2006-02-03 2010-12-28 Biomet Sports Medicine, Llc Soft tissue repair and conduit device
WO2011005185A1 (en) * 2009-07-10 2011-01-13 Milux Holding S.A. Implantable medical device for lubrication of a synovial joint and method for implanting the device
US20110014705A1 (en) * 2009-07-16 2011-01-20 Biomet Biologics, Llc Method and apparatus for separating biological materials
US7905904B2 (en) 2006-02-03 2011-03-15 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US7905903B2 (en) 2006-02-03 2011-03-15 Biomet Sports Medicine, Llc Method for tissue fixation
US7909851B2 (en) 2006-02-03 2011-03-22 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US7914539B2 (en) 2004-11-09 2011-03-29 Biomet Sports Medicine, Llc Tissue fixation device
US7914808B2 (en) 2001-07-16 2011-03-29 Depuy Products, Inc. Hybrid biologic/synthetic porous extracellular matrix scaffolds
US20110091517A1 (en) * 2002-10-18 2011-04-21 Depuy Mitek, Inc. Biocompatible scaffolds with tissue fragments
US7959650B2 (en) 2006-09-29 2011-06-14 Biomet Sports Medicine, Llc Adjustable knotless loops
US20110185560A1 (en) * 2008-08-18 2011-08-04 Qioptiq Photonics Gmbh & Co. Kg Method for producing an objective
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US8016867B2 (en) 1999-07-23 2011-09-13 Depuy Mitek, Inc. Graft fixation device and method
US8034090B2 (en) 2004-11-09 2011-10-11 Biomet Sports Medicine, Llc Tissue fixation device
US8088130B2 (en) 2006-02-03 2012-01-03 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US8118836B2 (en) 2004-11-05 2012-02-21 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US8128658B2 (en) 2004-11-05 2012-03-06 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to bone
US8128640B2 (en) 2005-02-07 2012-03-06 Ivy Sports Medicine LLC System and method for all-inside suture fixation for implant attachment and soft tissue repair
US8137686B2 (en) 2004-04-20 2012-03-20 Depuy Mitek, Inc. Nonwoven tissue scaffold
US8137354B2 (en) 2007-04-25 2012-03-20 Biomet Sports Medicine, Llc Localized cartilage defect therapy
US8137382B2 (en) 2004-11-05 2012-03-20 Biomet Sports Medicine, Llc Method and apparatus for coupling anatomical features
US20120114755A1 (en) * 2009-06-22 2012-05-10 Mayo Foundation For Medical Education And Research Methods and materials for tissue repair
US8221780B2 (en) 2004-04-20 2012-07-17 Depuy Mitek, Inc. Nonwoven tissue scaffold
US8221454B2 (en) 2004-02-20 2012-07-17 Biomet Sports Medicine, Llc Apparatus for performing meniscus repair
US8251998B2 (en) 2006-08-16 2012-08-28 Biomet Sports Medicine, Llc Chondral defect repair
US8298262B2 (en) 2006-02-03 2012-10-30 Biomet Sports Medicine, Llc Method for tissue fixation
US8303604B2 (en) 2004-11-05 2012-11-06 Biomet Sports Medicine, Llc Soft tissue repair device and method
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
US8343227B2 (en) 2009-05-28 2013-01-01 Biomet Manufacturing Corp. Knee prosthesis assembly with ligament link
US8361113B2 (en) 2006-02-03 2013-01-29 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US20130060334A1 (en) * 2010-02-25 2013-03-07 Orteq B.V. Meniscus repair assembly and method
US8500818B2 (en) 2006-09-29 2013-08-06 Biomet Manufacturing, Llc Knee prosthesis assembly with ligament link
US8506597B2 (en) 2011-10-25 2013-08-13 Biomet Sports Medicine, Llc Method and apparatus for interosseous membrane reconstruction
US8562647B2 (en) 2006-09-29 2013-10-22 Biomet Sports Medicine, Llc Method and apparatus for securing soft tissue to bone
US8562645B2 (en) 2006-09-29 2013-10-22 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable loop
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8574235B2 (en) 2006-02-03 2013-11-05 Biomet Sports Medicine, Llc Method for trochanteric reattachment
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US8597327B2 (en) 2006-02-03 2013-12-03 Biomet Manufacturing, Llc Method and apparatus for sternal closure
US8652171B2 (en) 2006-02-03 2014-02-18 Biomet Sports Medicine, Llc Method and apparatus for soft tissue fixation
US8652172B2 (en) 2006-02-03 2014-02-18 Biomet Sports Medicine, Llc Flexible anchors for tissue fixation
US8672969B2 (en) 2006-09-29 2014-03-18 Biomet Sports Medicine, Llc Fracture fixation device
US8691259B2 (en) 2000-12-21 2014-04-08 Depuy Mitek, Llc Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US8771352B2 (en) 2011-05-17 2014-07-08 Biomet Sports Medicine, Llc Method and apparatus for tibial fixation of an ACL graft
US8783470B2 (en) 2009-03-06 2014-07-22 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8801783B2 (en) 2006-09-29 2014-08-12 Biomet Sports Medicine, Llc Prosthetic ligament system for knee joint
US8840645B2 (en) 2004-11-05 2014-09-23 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US8895045B2 (en) 2003-03-07 2014-11-25 Depuy Mitek, Llc Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
US8936621B2 (en) 2006-02-03 2015-01-20 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable loop
US8968364B2 (en) 2006-02-03 2015-03-03 Biomet Sports Medicine, Llc Method and apparatus for fixation of an ACL graft
US8998949B2 (en) 2004-11-09 2015-04-07 Biomet Sports Medicine, Llc Soft tissue conduit device
US9017381B2 (en) 2007-04-10 2015-04-28 Biomet Sports Medicine, Llc Adjustable knotless loops
US9078644B2 (en) 2006-09-29 2015-07-14 Biomet Sports Medicine, Llc Fracture fixation device
US20150224147A1 (en) * 2013-01-30 2015-08-13 Nu Tech Medical, Inc. Placental Membrane Preparation and Methods of Making and Using Same
US9149267B2 (en) 2006-02-03 2015-10-06 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US9259217B2 (en) 2012-01-03 2016-02-16 Biomet Manufacturing, Llc Suture Button
US9271713B2 (en) 2006-02-03 2016-03-01 Biomet Sports Medicine, Llc Method and apparatus for tensioning a suture
US9314241B2 (en) 2011-11-10 2016-04-19 Biomet Sports Medicine, Llc Apparatus for coupling soft tissue to a bone
US9357991B2 (en) 2011-11-03 2016-06-07 Biomet Sports Medicine, Llc Method and apparatus for stitching tendons
US9370350B2 (en) 2011-11-10 2016-06-21 Biomet Sports Medicine, Llc Apparatus for coupling soft tissue to a bone
US9381013B2 (en) 2011-11-10 2016-07-05 Biomet Sports Medicine, Llc Method for coupling soft tissue to a bone
US9538998B2 (en) 2006-02-03 2017-01-10 Biomet Sports Medicine, Llc Method and apparatus for fracture fixation
US9556243B2 (en) 2013-03-15 2017-01-31 Biomet Biologies, LLC Methods for making cytokine compositions from tissues using non-centrifugal methods
US9615822B2 (en) 2014-05-30 2017-04-11 Biomet Sports Medicine, Llc Insertion tools and method for soft anchor
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9701940B2 (en) 2005-09-19 2017-07-11 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
US9701728B2 (en) 2008-02-27 2017-07-11 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
US9700291B2 (en) 2014-06-03 2017-07-11 Biomet Sports Medicine, Llc Capsule retractor
US9757119B2 (en) 2013-03-08 2017-09-12 Biomet Sports Medicine, Llc Visual aid for identifying suture limbs arthroscopically
US9801708B2 (en) 2004-11-05 2017-10-31 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US9897589B2 (en) 2002-05-24 2018-02-20 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9918827B2 (en) 2013-03-14 2018-03-20 Biomet Sports Medicine, Llc Scaffold for spring ligament repair
US9918826B2 (en) 2006-09-29 2018-03-20 Biomet Sports Medicine, Llc Scaffold for spring ligament repair
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US9955980B2 (en) 2015-02-24 2018-05-01 Biomet Sports Medicine, Llc Anatomic soft tissue repair
US10039543B2 (en) 2014-08-22 2018-08-07 Biomet Sports Medicine, Llc Non-sliding soft anchor
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
US10136886B2 (en) 2013-12-20 2018-11-27 Biomet Sports Medicine, Llc Knotless soft tissue devices and techniques
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US10441634B2 (en) 2013-03-15 2019-10-15 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10517587B2 (en) 2006-02-03 2019-12-31 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable loop
US10576130B2 (en) 2013-03-15 2020-03-03 Biomet Manufacturing, Llc Treatment of collagen defects using protein solutions
US10912551B2 (en) 2015-03-31 2021-02-09 Biomet Sports Medicine, Llc Suture anchor with soft anchor of electrospun fibers
US10932769B2 (en) 2016-05-26 2021-03-02 Ivy Sports Medicine, Llc System and method for all-inside suture fixation for implant attachment and soft tissue repair
US11259792B2 (en) 2006-02-03 2022-03-01 Biomet Sports Medicine, Llc Method and apparatus for coupling anatomical features
US11259794B2 (en) 2006-09-29 2022-03-01 Biomet Sports Medicine, Llc Method for implanting soft tissue
US11311287B2 (en) 2006-02-03 2022-04-26 Biomet Sports Medicine, Llc Method for tissue fixation
US11395865B2 (en) 2004-02-09 2022-07-26 DePuy Synthes Products, Inc. Scaffolds with viable tissue

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7374678B2 (en) * 2002-05-24 2008-05-20 Biomet Biologics, Inc. Apparatus and method for separating and concentrating fluids containing multiple components
US8138265B2 (en) 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8137688B2 (en) 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US7465766B2 (en) 2004-01-08 2008-12-16 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US6982298B2 (en) 2003-01-10 2006-01-03 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US6994730B2 (en) 2003-01-31 2006-02-07 Howmedica Osteonics Corp. Meniscal and tibial implants
AU2003900620A0 (en) * 2003-02-12 2003-02-27 Australian Surgical Design And Manufacture Pty Limited Arthroscopic chondrocyte implantation method and device
JP4215595B2 (en) 2003-08-21 2009-01-28 安正 赤川 Implant fixing member and implant composite material
DE10348219A1 (en) * 2003-10-13 2005-05-12 Aesculap Ag & Co Kg Cartilage replacement implant and method of making a cartilage replacement implant
US8657881B2 (en) * 2004-04-20 2014-02-25 Depuy Mitek, Llc Meniscal repair scaffold
US20060002967A1 (en) * 2004-07-01 2006-01-05 Smestad Thomas L Resorbable implant with lubricious coating
US20080220044A1 (en) * 2007-03-06 2008-09-11 Semler Eric J Cancellous construct with support ring for repair of osteochondral defects
US20070014729A1 (en) * 2005-06-09 2007-01-18 The Hospital For Sick Children Tissue engineered scaffolds and mehtods of preparation thereof
US20060280768A1 (en) * 2005-06-13 2006-12-14 Julia Hwang Meniscal repair device and method
US20070074980A1 (en) * 2005-09-02 2007-04-05 Bankoski Brian R Implant rehydration packages and methods of use
AU2013222002B2 (en) * 2005-09-09 2016-06-02 Cytex Therapeutics, Inc. Tissue engineering methods and compositions
WO2007070546A2 (en) * 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Meniscal implant of hyaluronic acid derivatives for treatment of meniscal defects
US20070202084A1 (en) * 2005-12-14 2007-08-30 Anika Therapeutics, Inc. Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
US20070233268A1 (en) * 2006-03-31 2007-10-04 Depuy Products, Inc. Interpositional knee arthroplasty
US20080097606A1 (en) * 2006-10-19 2008-04-24 Cragg Andrew H Knee joint prosthesis and hyaluronate compositions for treatment of osteoarthritis
US10278947B2 (en) 2007-02-28 2019-05-07 Orthopeutics, L.P. Crosslinker enhanced repair of connective tissues
WO2011150218A1 (en) * 2010-05-27 2011-12-01 Hedman Thomas P Crosslinker enhanced repair of knee meniscus
US8080260B2 (en) 2008-02-13 2011-12-20 The Cleveland Clinic Foundation Molecular enhancement of extracellular matrix and methods of use
WO2009135029A2 (en) 2008-04-30 2009-11-05 The Cleveland Clinic Foundation Compositions and methods to treat urinary incontinence
US20100145451A1 (en) 2008-12-04 2010-06-10 Derek Dee Joint support and subchondral support system
US10610364B2 (en) 2008-12-04 2020-04-07 Subchondral Solutions, Inc. Method for ameliorating joint conditions and diseases and preventing bone hypertrophy
WO2010096824A1 (en) * 2009-02-23 2010-08-26 Bartee Barry K Reinforced ptfe medical barrier
US8241298B2 (en) 2009-03-27 2012-08-14 Depuy Mitek, Inc. Methods and devices for delivering and affixing tissue scaffolds
US8308814B2 (en) 2009-03-27 2012-11-13 Depuy Mitek, Inc. Methods and devices for preparing and implanting tissue scaffolds
US8444699B2 (en) * 2010-02-18 2013-05-21 Biomet Manufacturing Corp. Method and apparatus for augmenting bone defects
US8727203B2 (en) 2010-09-16 2014-05-20 Howmedica Osteonics Corp. Methods for manufacturing porous orthopaedic implants
EP2640430B1 (en) * 2010-11-17 2016-03-09 Zimmer, Inc. Ceramic monoblock implants with osseointegration fixation surfaces
JP5679889B2 (en) * 2011-04-20 2015-03-04 株式会社エム・エム・ティー Plug member for bone hole
EP3798226A1 (en) 2013-02-01 2021-03-31 Children's Medical Center Corporation Collagen scaffolds
US9345589B2 (en) * 2013-12-19 2016-05-24 Ilion Medical, Inc. Bone implants for orthopedic procedures and corresponding methods
GB2523593A (en) * 2014-02-28 2015-09-02 Adrian Robert Ford Method, design and preparation of a biological implant with enhanced biological activity via modification of the plastic deformation characteristics
US9801910B2 (en) 2014-03-17 2017-10-31 Ethicon, Inc. Decellularized pleural matrix
WO2016033337A1 (en) 2014-08-27 2016-03-03 The Cleveland Clinic Foundation Biocompatible tissue graft
US10524774B2 (en) 2015-04-02 2020-01-07 Arthrex, Inc. Method of repairing cartilage defects
US10524775B2 (en) 2015-07-02 2020-01-07 Arthrex, Inc. Methods of repairing cartilage defects
US20170051016A1 (en) 2015-08-17 2017-02-23 Northwestern University Anti-inflammatory nanofibers
EP3838195A1 (en) 2015-11-25 2021-06-23 Subchondral Solutions, Inc. Methods, systems and devices for repairing anatomical joint conditions
US10786370B2 (en) * 2017-12-28 2020-09-29 Industrial Technology Research Institute Cartilage repair implant, auxiliary surgical tool kit and cartilage repair system

Citations (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3272204A (en) * 1965-09-22 1966-09-13 Ethicon Inc Absorbable collagen prosthetic implant with non-absorbable reinforcing strands
US4105034A (en) * 1977-06-10 1978-08-08 Ethicon, Inc. Poly(alkylene oxalate) absorbable coating for sutures
US4140678A (en) * 1977-06-13 1979-02-20 Ethicon, Inc. Synthetic absorbable surgical devices of poly(alkylene oxalates)
US4141087A (en) * 1977-01-19 1979-02-27 Ethicon, Inc. Isomorphic copolyoxalates and sutures thereof
US4205399A (en) * 1977-06-13 1980-06-03 Ethicon, Inc. Synthetic absorbable surgical devices of poly(alkylene oxalates)
US4206511A (en) * 1977-05-18 1980-06-03 Mannesmann Aktiengesellschaft Locating a welding seam
US4610397A (en) * 1983-10-27 1986-09-09 Urschel Laboratories Incorporated Comminuting equipment
US4669473A (en) * 1985-09-06 1987-06-02 Acufex Microsurgical, Inc. Surgical fastener
US4736372A (en) * 1985-09-13 1988-04-05 Siemens Aktiengesellschaft Method and apparatus of transmission for a digital signal
US4741330A (en) * 1983-05-19 1988-05-03 Hayhurst John O Method and apparatus for anchoring and manipulating cartilage
US4750492A (en) * 1985-02-27 1988-06-14 Richards Medical Company Absorbable suture apparatus, method and installer
US4846835A (en) * 1987-06-15 1989-07-11 Grande Daniel A Technique for healing lesions in cartilage
US4956179A (en) * 1971-11-01 1990-09-11 Astra Lakemedel Aktiebolag Antibacterial combination of penicillin and cephalosporin
US5102421A (en) * 1990-06-14 1992-04-07 Wm. E. Anpach, III Suture anchor and method of forming
USRE34021E (en) * 1985-11-18 1992-08-04 Abbott Laboratories Percutaneous fixation of hollow organs
US5350583A (en) * 1988-03-09 1994-09-27 Terumo Kabushiki Kaisha Cell-penetrable medical material and artificial skin
US5447940A (en) * 1993-07-28 1995-09-05 Johnson & Johnson Medical, Inc. Absorbable composite materials for use in the treatment of periodontal disease
US5514181A (en) * 1993-09-29 1996-05-07 Johnson & Johnson Medical, Inc. Absorbable structures for ligament and tendon repair
US5520691A (en) * 1990-11-06 1996-05-28 Branch; Thomas P. Method and apparatus for re-approximating tissue
US5545178A (en) * 1994-04-29 1996-08-13 Kensey Nash Corporation System for closing a percutaneous puncture formed by a trocar to prevent tissue at the puncture from herniating
US5595751A (en) * 1995-03-06 1997-01-21 Ethicon, Inc. Absorbable polyoxaesters containing amines and/or amido groups
US5597579A (en) * 1995-03-06 1997-01-28 Ethicon, Inc. Blends of absorbable polyoxaamides
US5607687A (en) * 1995-03-06 1997-03-04 Ethicon, Inc. Polymer blends containing absorbable polyoxaesters
US5618552A (en) * 1995-03-06 1997-04-08 Ethicon, Inc. Absorbable polyoxaesters
US5620698A (en) * 1995-03-06 1997-04-15 Ethicon, Inc. Blends of absorbable polyoxaesters containing amines and/or amido groups
US5626614A (en) * 1995-12-22 1997-05-06 Applied Medical Resources Corporation T-anchor suturing device and method for using same
US5630824A (en) * 1994-06-01 1997-05-20 Innovasive Devices, Inc. Suture attachment device
US5660225A (en) * 1993-08-30 1997-08-26 Saffran; Bruce Nathan Method of fracture treatment by restraining macromolecules or macromolecular aggregates adjacent to damaged tissues
US5725556A (en) * 1995-12-15 1998-03-10 M & R Medical, Inc. Suture locking apparatus
US5736372A (en) * 1986-11-20 1998-04-07 Massachusetts Institute Of Technology Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
US5735897A (en) * 1993-10-19 1998-04-07 Scimed Life Systems, Inc. Intravascular stent pump
US5759208A (en) * 1996-02-29 1998-06-02 The Procter & Gamble Company Laundry detergent compositions containing silicone emulsions
US5773577A (en) * 1994-03-03 1998-06-30 Protein Polymer Technologies Products comprising substrates capable of enzymatic cross-linking
US5855610A (en) * 1995-05-19 1999-01-05 Children's Medical Center Corporation Engineering of strong, pliable tissues
US5859150A (en) * 1995-03-06 1999-01-12 Ethicon, Inc. Prepolymers of absorbable polyoxaesters
US5861004A (en) * 1991-11-08 1999-01-19 Kensey Nash Corporation Hemostatic puncture closure system including closure locking means and method of use
US5863551A (en) * 1996-10-16 1999-01-26 Organogel Canada Ltee Implantable polymer hydrogel for therapeutic uses
US5866165A (en) * 1997-01-15 1999-02-02 Orquest, Inc. Collagen-polysaccharide matrix for bone and cartilage repair
US5891558A (en) * 1994-11-22 1999-04-06 Tissue Engineering, Inc. Biopolymer foams for use in tissue repair and reconstruction
US5893888A (en) * 1992-08-07 1999-04-13 Tissue Engineering, Inc. Method and construct for producing graft tissue from extracellular matrix
US5899939A (en) * 1998-01-21 1999-05-04 Osteotech, Inc. Bone-derived implant for load-supporting applications
US5906997A (en) * 1997-06-17 1999-05-25 Fzio Med, Inc. Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
US5939323A (en) * 1996-05-28 1999-08-17 Brown University Hyaluronan based biodegradable scaffolds for tissue repair
US6010525A (en) * 1997-08-01 2000-01-04 Peter M. Bonutti Method and apparatus for securing a suture
US6066160A (en) * 1998-11-23 2000-05-23 Quickie Llc Passive knotless suture terminator for use in minimally invasive surgery and to facilitate standard tissue securing
US6077989A (en) * 1996-05-28 2000-06-20 Kandel; Rita Resorbable implant biomaterial made of condensed calcium phosphate particles
US6110212A (en) * 1994-11-15 2000-08-29 Kenton W. Gregory Elastin and elastin-based materials
US6197296B1 (en) * 1993-03-29 2001-03-06 National Heart Research Fund Tissue equivalents
US6214048B1 (en) * 1992-02-10 2001-04-10 Matsumoto Dental College Bone substitute product and method of producing the same
US20010002446A1 (en) * 1996-04-05 2001-05-31 Plouhar Pamela L. Tissue graft construct for replacement of cartilaginous structures
US6242247B1 (en) * 1996-06-04 2001-06-05 Sulzer Orthopedics Ltd. Method for making cartilage and implants
US6258124B1 (en) * 1999-05-10 2001-07-10 C. R. Bard, Inc. Prosthetic repair fabric
US6264702B1 (en) * 1997-08-01 2001-07-24 Sofradim Production Composite prosthesis for preventing post-surgical adhesions
US6265333B1 (en) * 1998-06-02 2001-07-24 Board Of Regents, University Of Nebraska-Lincoln Delamination resistant composites prepared by small diameter fiber reinforcement at ply interfaces
US6267957B1 (en) * 1998-01-20 2001-07-31 Howard Green Attaching agents to tissue with transglutaminase and a transglutaminase substrate
US6270530B1 (en) * 1997-05-01 2001-08-07 C.R. Bard, Inc. Prosthetic repair fabric
US6280474B1 (en) * 1997-01-09 2001-08-28 Neucoll, Inc. Devices for tissue repair and methods for preparation and use thereof
US6280473B1 (en) * 1996-08-19 2001-08-28 Macropore, Inc. Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration
US20020031551A1 (en) * 1996-04-16 2002-03-14 Peterson Dale R. Bioerodable polymeric adhesives for tissue repair
US6358284B1 (en) * 1996-12-10 2002-03-19 Med Institute, Inc. Tubular grafts from purified submucosa
US20020038151A1 (en) * 2000-08-04 2002-03-28 Plouhar Pamela L. Reinforced small intestinal submucosa (SIS)
US6373221B2 (en) * 1999-12-27 2002-04-16 Kabushiki Kaisha Toyoda Jidoshokki Seisakusho Charger coupling
US20020052628A1 (en) * 1999-07-23 2002-05-02 Bowman Steven M. Graft fixation device and method
US6402766B2 (en) * 1999-07-23 2002-06-11 Ethicon, Inc. Graft fixation device combination
US20020095157A1 (en) * 1999-07-23 2002-07-18 Bowman Steven M. Graft fixation device combination
US6423073B2 (en) * 1999-07-23 2002-07-23 Ethicon, Inc. Instrument for inserting graft fixation device
US6436110B2 (en) * 1999-07-23 2002-08-20 Ethicon, Inc. Method of securing a graft using a graft fixation device
US6440444B2 (en) * 1999-02-23 2002-08-27 Osteotech, Inc. Load bearing osteoimplant and method of repairing bone using the same
US20030014126A1 (en) * 2001-06-28 2003-01-16 Patel Umesh H. Graft prosthesis devices containing renal capsule collagen
US6508821B1 (en) * 2000-01-28 2003-01-21 Depuy Orthopaedics, Inc. Soft tissue repair material fixation apparatus and method
US20030021827A1 (en) * 2001-07-16 2003-01-30 Prasanna Malaviya Hybrid biologic/synthetic porous extracellular matrix scaffolds
US20030023316A1 (en) * 2000-08-04 2003-01-30 Brown Laura Jean Hybrid biologic-synthetic bioabsorable scaffolds
US6517564B1 (en) * 1999-02-02 2003-02-11 Arthrex, Inc. Bioabsorbable tissue tack with oval-shaped head and method of tissue fixation using same
US20030032961A1 (en) * 2001-07-16 2003-02-13 Pelo Mark Joseph Devices from naturally occurring biologically derived materials
US20030033022A1 (en) * 2001-07-16 2003-02-13 Plouhar Pamela Lynn Cartilage repair and regeneration device and method
US20030036797A1 (en) * 2001-07-16 2003-02-20 Prasanna Malaviya Meniscus regeneration device and method
US20030036801A1 (en) * 2001-07-16 2003-02-20 Schwartz Herbert E. Cartilage repair apparatus and method
US20030044444A1 (en) * 2001-07-16 2003-03-06 Prasanna Malaviya Porous extracellular matrix scaffold and method
US20030049299A1 (en) * 2001-07-16 2003-03-13 Prasanna Malaviya Porous delivery scaffold and method
US20030078617A1 (en) * 2001-07-16 2003-04-24 Schwartz Herbert E. Unitary surgical device and method
US6566345B2 (en) * 2000-04-28 2003-05-20 Fziomed, Inc. Polyacid/polyalkylene oxide foams and gels and methods for their delivery
US6572650B1 (en) * 1998-06-05 2003-06-03 Organogenesis Inc. Bioengineered vascular graft support prostheses
US6592623B1 (en) * 1999-08-31 2003-07-15 Virginia Commonwealth University Intellectual Property Foundation Engineered muscle
US6692499B2 (en) * 1997-07-02 2004-02-17 Linvatec Biomaterials Oy Surgical fastener for tissue treatment
US20040143344A1 (en) * 2001-07-16 2004-07-22 Prasanna Malaviya Implantable tissue repair device and method
US20040166169A1 (en) * 2002-07-15 2004-08-26 Prasanna Malaviya Porous extracellular matrix scaffold and method
US6840962B1 (en) * 1995-05-01 2005-01-11 Massachusetts Institute Of Technology Tissue engineered tendons and ligaments
US6869938B1 (en) * 1997-06-17 2005-03-22 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use in reducing adhesions
US6989034B2 (en) * 2002-05-31 2006-01-24 Ethicon, Inc. Attachment of absorbable tissue scaffolds to fixation devices

Family Cites Families (164)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT261800B (en) * 1966-08-22 1968-05-10 Braun Internat Gmbh B Process for the manufacture of tubular, smooth or threaded tissue-blood vessel prostheses
US4208511A (en) * 1977-01-19 1980-06-17 Ethicon, Inc. Isomorphic copolyoxalates and sutures thereof
US4130639A (en) * 1977-09-28 1978-12-19 Ethicon, Inc. Absorbable pharmaceutical compositions based on isomorphic copolyoxalates
US4352463A (en) * 1979-01-18 1982-10-05 Leisure Lawn, Inc. Motorized combination wet and dry lawn treatment spreader
US4400833A (en) 1981-06-10 1983-08-30 Kurland Kenneth Z Means and method of implanting bioprosthetics
US4418691A (en) * 1981-10-26 1983-12-06 Massachusetts Institute Of Technology Method of promoting the regeneration of tissue at a wound
IL68218A (en) * 1983-03-23 1985-12-31 Univ Ramot Compositions for cartilage repair comprising embryonal chondrocytes
US4873976A (en) 1984-02-28 1989-10-17 Schreiber Saul N Surgical fasteners and method
CA1295796C (en) * 1984-03-27 1992-02-18 Conrad Whyne Biodegradable matrix and methods for producing same
US5128326A (en) 1984-12-06 1992-07-07 Biomatrix, Inc. Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
US4705040A (en) * 1985-11-18 1987-11-10 Medi-Tech, Incorporated Percutaneous fixation of hollow organs
US4924865A (en) * 1986-05-20 1990-05-15 Concept, Inc. Repair tack for bodily tissue
US5007934A (en) 1987-07-20 1991-04-16 Regen Corporation Prosthetic meniscus
US4880429A (en) 1987-07-20 1989-11-14 Stone Kevin R Prosthetic meniscus
US5681353A (en) 1987-07-20 1997-10-28 Regen Biologics, Inc. Meniscal augmentation device
US5306311A (en) * 1987-07-20 1994-04-26 Regen Corporation Prosthetic articular cartilage
US5108438A (en) * 1989-03-02 1992-04-28 Regen Corporation Prosthetic intervertebral disc
GB2215209B (en) 1988-03-14 1992-08-26 Osmed Inc Method and apparatus for biodegradable, osteogenic, bone graft substitute device
US6010692A (en) * 1988-05-31 2000-01-04 University Of Florida Research Foundation, Inc. Method and composition for preventing surgical adhesions and tissue damage
US4956178A (en) 1988-07-11 1990-09-11 Purdue Research Foundation Tissue graft composition
US4902508A (en) * 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
US4919667A (en) 1988-12-02 1990-04-24 Stryker Corporation Implant
US5376118A (en) * 1989-05-10 1994-12-27 United States Surgical Corporation Support material for cell impregnation
US5158573A (en) * 1989-06-09 1992-10-27 American Medical Systems, Inc. Injectable polymeric bodies
US5061286A (en) * 1989-08-18 1991-10-29 Osteotech, Inc. Osteoprosthetic implant
US5129906A (en) 1989-09-08 1992-07-14 Linvatec Corporation Bioabsorbable tack for joining bodily tissue and in vivo method and apparatus for deploying same
JPH03260178A (en) 1990-03-06 1991-11-20 Showa Shell Sekiyu Kk Production of water-absorbing and water-retaining flexible cloth
US5269809A (en) * 1990-07-02 1993-12-14 American Cyanamid Company Locking mechanism for use with a slotted suture anchor
US5258015A (en) * 1991-05-03 1993-11-02 American Cyanamid Company Locking filament caps
US5269783A (en) 1991-05-13 1993-12-14 United States Surgical Corporation Device and method for repairing torn tissue
US5236431A (en) 1991-07-22 1993-08-17 Synthes Resorbable fixation device with controlled stiffness for treating bodily material in vivo and introducer therefor
US5329846A (en) * 1991-08-12 1994-07-19 Bonutti Peter M Tissue press and system
US5281422A (en) 1991-09-24 1994-01-25 Purdue Research Foundation Graft for promoting autogenous tissue growth
IT1254712B (en) 1992-01-20 1995-10-09 USE OF HYALURONIC LUBRICANT OF EYE PROSTHESIS.
ZA93506B (en) * 1992-02-11 1994-05-11 Bristol Myers Squibb Co Soft tissue augmentation material
WO1993017635A1 (en) 1992-03-04 1993-09-16 C.R. Bard, Inc. Composite prosthesis and method for limiting the incidence of postoperative adhesions
US5289809A (en) * 1992-03-17 1994-03-01 Nippondenso Co., Ltd. Internal combustion engine control apparatus
US5800537A (en) 1992-08-07 1998-09-01 Tissue Engineering, Inc. Method and construct for producing graft tissue from an extracellular matrix
US5383905A (en) 1992-10-09 1995-01-24 United States Surgical Corporation Suture loop locking device
DE4236237A1 (en) 1992-10-27 1994-04-28 Behringwerke Ag Prodrugs, their preparation and use as medicines
US5641518A (en) * 1992-11-13 1997-06-24 Purdue Research Foundation Method of repairing bone tissue
US5352463A (en) * 1992-11-13 1994-10-04 Badylak Steven F Tissue graft for surgical reconstruction of a collagenous meniscus and method therefor
US5275826A (en) * 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
US5320633A (en) * 1992-12-10 1994-06-14 William C. Allen Method and system for repairing a tear in the meniscus
DE4302709C1 (en) 1993-02-01 1994-07-28 Kirsch Axel Cover device with cover membrane
US5380334A (en) * 1993-02-17 1995-01-10 Smith & Nephew Dyonics, Inc. Soft tissue anchors and systems for implantation
US5500000A (en) 1993-07-01 1996-03-19 United States Surgical Corporation Soft tissue repair system and method
WO1995005083A1 (en) * 1993-08-13 1995-02-23 Smith & Nephew Richards Inc Microporous polymeric foams and microtextured surfaces
US5989280A (en) * 1993-10-22 1999-11-23 Scimed Lifesystems, Inc Stent delivery apparatus and method
US5460962A (en) 1994-01-04 1995-10-24 Organogenesis Inc. Peracetic acid sterilization of collagen or collagenous tissue
US5759205A (en) 1994-01-21 1998-06-02 Brown University Research Foundation Negatively charged polymeric electret implant
US6334872B1 (en) 1994-02-18 2002-01-01 Organogenesis Inc. Method for treating diseased or damaged organs
US5916265A (en) 1994-03-30 1999-06-29 Hu; Jie Method of producing a biological extracellular matrix for use as a cell seeding scaffold and implant
US5501685A (en) 1994-04-26 1996-03-26 Spetzler; Robert F. Method for securing a cranial piece in position
US5954723A (en) 1994-04-26 1999-09-21 Spetzler; Robert F. Method and apparatus for securing a cranial plate with pins
CA2188563C (en) * 1994-04-29 2005-08-02 Andrew W. Buirge Stent with collagen
US5556429A (en) 1994-05-06 1996-09-17 Advanced Bio Surfaces, Inc. Joint resurfacing system
US5981825A (en) * 1994-05-13 1999-11-09 Thm Biomedical, Inc. Device and methods for in vivo culturing of diverse tissue cells
US5479033A (en) 1994-05-27 1995-12-26 Sandia Corporation Complementary junction heterostructure field-effect transistor
JPH10505250A (en) 1994-06-06 1998-05-26 ケース ウエスターン リザーブ ユニバーシティ Biomatrix for tissue regeneration
US5632745A (en) * 1995-02-07 1997-05-27 R&D Biologicals, Inc. Surgical implantation of cartilage repair unit
US5769899A (en) 1994-08-12 1998-06-23 Matrix Biotechnologies, Inc. Cartilage repair unit
US5569252A (en) 1994-09-27 1996-10-29 Justin; Daniel F. Device for repairing a meniscal tear in a knee and method
US5709934A (en) * 1994-11-22 1998-01-20 Tissue Engineering, Inc. Bipolymer foams having extracellular matrix particulates
US6235057B1 (en) 1995-01-24 2001-05-22 Smith & Nephew, Inc. Method for soft tissue reconstruction
US6080194A (en) * 1995-02-10 2000-06-27 The Hospital For Joint Disease Orthopaedic Institute Multi-stage collagen-based template or implant for use in the repair of cartilage lesions
US5695998A (en) 1995-02-10 1997-12-09 Purdue Research Foundation Submucosa as a growth substrate for islet cells
GB9503492D0 (en) 1995-02-22 1995-04-12 Ed Geistlich S Hne A G F R Che Chemical product
GB9721585D0 (en) * 1997-10-10 1997-12-10 Geistlich Soehne Ag Chemical product
US5464929A (en) * 1995-03-06 1995-11-07 Ethicon, Inc. Absorbable polyoxaesters
US5700583A (en) * 1995-03-06 1997-12-23 Ethicon, Inc. Hydrogels of absorbable polyoxaesters containing amines or amido groups
US5698213A (en) * 1995-03-06 1997-12-16 Ethicon, Inc. Hydrogels of absorbable polyoxaesters
US5782835A (en) 1995-03-07 1998-07-21 Innovasive Devices, Inc. Apparatus and methods for articular cartilage defect repair
CA2173508A1 (en) 1995-03-31 1996-10-01 Tooru Yui Medical device and method for producing the same
US5711969A (en) 1995-04-07 1998-01-27 Purdue Research Foundation Large area submucosal tissue graft constructs
US5733337A (en) 1995-04-07 1998-03-31 Organogenesis, Inc. Tissue repair fabric
DE69622548T2 (en) * 1995-04-07 2003-09-18 Purdue Research Foundation West Lafayette TISSUE TRANSPLANT FOR BUBBLE RECONSTRUCTION
US5554389A (en) 1995-04-07 1996-09-10 Purdue Research Foundation Urinary bladder submucosa derived tissue graft
US6060640A (en) 1995-05-19 2000-05-09 Baxter International Inc. Multiple-layer, formed-in-place immunoisolation membrane structures for implantation of cells in host tissue
US5830708A (en) * 1995-06-06 1998-11-03 Advanced Tissue Sciences, Inc. Methods for production of a naturally secreted extracellular matrix
US5759206A (en) * 1995-09-18 1998-06-02 Bassett; David E. Apparatus for mounting a prosthesis or the like
US5855613A (en) * 1995-10-13 1999-01-05 Islet Sheet Medical, Inc. Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change
US5965125A (en) * 1995-10-25 1999-10-12 Transkaryotic Therapies, Inc. Hybrid matrix implants and explants
AU7274696A (en) * 1995-11-06 1997-05-29 Mount Sinai Hospital Corporation Reconstituted mineralized cartilage tissue
US5702462A (en) 1996-01-24 1997-12-30 Oberlander; Michael Method of meniscal repair
US5842477A (en) 1996-02-21 1998-12-01 Advanced Tissue Sciences, Inc. Method for repairing cartilage
US5817095A (en) * 1996-02-22 1998-10-06 Smith & Nephew, Inc. Undercutting surgical instrument
US5755791A (en) 1996-04-05 1998-05-26 Purdue Research Foundation Perforated submucosal tissue graft constructs
US5733868A (en) 1996-04-16 1998-03-31 Depuy Orthopaedics, Inc. Poly(amino acid) adhesive tissue grafts
US5668288A (en) 1996-04-16 1997-09-16 Depuy Orthopaedics, Inc. Polyester ionomers for implant fabrication
US5730933A (en) 1996-04-16 1998-03-24 Depuy Orthopaedics, Inc. Radiation sterilization of biologically active compounds
US5834232A (en) * 1996-05-01 1998-11-10 Zymogenetics, Inc. Cross-linked gelatin gels and methods of making them
IT1288290B1 (en) 1996-06-21 1998-09-11 Fidia Spa In Amministrazione S SELF-LETICULATED HYALURONIC ACID AND RELATED PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ARTHROPATHIES
US6171344B1 (en) 1996-08-16 2001-01-09 Children's Medical Center Corporation Bladder submucosa seeded with cells for tissue reconstruction
US6666892B2 (en) 1996-08-23 2003-12-23 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
AU742457B2 (en) 1996-08-23 2002-01-03 Cook Biotech, Incorporated Graft prosthesis, materials and methods
US5759190A (en) 1996-08-30 1998-06-02 Vts Holdings Limited Method and kit for autologous transplantation
US20020173806A1 (en) 1996-08-30 2002-11-21 Verigen Transplantation Service International (Vtsi) Ag Method for autologous transplantation
US5989269A (en) 1996-08-30 1999-11-23 Vts Holdings L.L.C. Method, instruments and kit for autologous transplantation
CA2267449C (en) 1996-11-05 2008-10-14 Purdue Research Foundation Myocardial graft constructs
AU7178698A (en) 1996-11-15 1998-06-03 Advanced Bio Surfaces, Inc. Biomaterial system for in situ tissue repair
JP4302188B2 (en) 1996-12-10 2009-07-22 パーデュー・リサーチ・ファウンデーション Gastric submucosa-derived tissue graft
AU732726B2 (en) 1996-12-10 2001-04-26 Purdue Research Foundation Biomaterial derived from vertebrate liver tissue
DK1671604T3 (en) 1996-12-10 2009-11-09 Purdue Research Foundation Synthetic tissue valve
CA2224366C (en) 1996-12-11 2006-10-31 Ethicon, Inc. Meniscal repair device
US6146385A (en) 1997-02-11 2000-11-14 Smith & Nephew, Inc. Repairing cartilage
GB9704288D0 (en) 1997-03-01 1997-04-23 Smith & Nephew Hydrogels
ATE229038T1 (en) * 1997-04-04 2002-12-15 Fidia Advanced Biopolymers Srl N-SULFATED HYALURONIC ACID COMPOUNDS, THEIR DERIVATIVES AND METHOD FOR THEIR PRODUCTION
US5993844A (en) 1997-05-08 1999-11-30 Organogenesis, Inc. Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix
US5980524A (en) 1997-06-02 1999-11-09 Innovasive Devices, Inc. Device for repairing a meniscal tear in a knee and method
FR2766717B1 (en) * 1997-08-01 2000-06-09 Cogent Sarl COMPOSITE PROSTHESIS FOR PREVENTION OF POST-SURGICAL ADHESIONS AND PROCESS FOR OBTAINING SAME
AUPP000797A0 (en) 1997-10-24 1997-11-20 Cryptych Pty Ltd Fixation of cruciate ligament grafts
US6056778A (en) 1997-10-29 2000-05-02 Arthrex, Inc. Meniscal repair device
US5954747A (en) 1997-11-20 1999-09-21 Clark; Ron Meniscus repair anchor system
US6214049B1 (en) 1999-01-14 2001-04-10 Comfort Biomedical, Inc. Method and apparatus for augmentating osteointegration of prosthetic implant devices
US6068648A (en) 1998-01-26 2000-05-30 Orthodyne, Inc. Tissue anchoring system and method
US6123731A (en) * 1998-02-06 2000-09-26 Osteotech, Inc. Osteoimplant and method for its manufacture
US5958874A (en) 1998-02-18 1999-09-28 The Research Foundation Of State University Of New York Recombinant fibronectin-based extracellular matrix for wound healing
US6056777A (en) 1998-02-27 2000-05-02 Mcdowell; Charles L. Method and device for regenerating cartilage in articulating
US6179872B1 (en) 1998-03-17 2001-01-30 Tissue Engineering Biopolymer matt for use in tissue repair and reconstruction
US5993475A (en) 1998-04-22 1999-11-30 Bristol-Myers Squibb Co. Tissue repair device
US6027744A (en) 1998-04-24 2000-02-22 University Of Massachusetts Medical Center Guided development and support of hydrogel-cell compositions
JPH11319068A (en) 1998-05-12 1999-11-24 Menicon Co Ltd Base material for artificial skin and production thereof
WO1999063051A2 (en) * 1998-06-05 1999-12-09 Organogenesis Inc. Bioengineered flat sheet graft prostheses
US5971987A (en) 1998-09-18 1999-10-26 Ethicon, Inc. Biocompatible absorbable polymer fastener and driver for use in surgical procedures
JP2002528567A (en) 1998-10-28 2002-09-03 アシュビー・サイエンティフィック・リミテッド Porous silicone rubber woven
US6409764B1 (en) * 1998-12-03 2002-06-25 Charles F. White Methods and articles for regenerating bone or peridontal tissue
US20020165611A1 (en) * 1998-12-22 2002-11-07 Robert-Jan Enzerink Graft material convenience package
US6306159B1 (en) 1998-12-23 2001-10-23 Depuy Orthopaedics, Inc. Meniscal repair device
US6326025B1 (en) 1998-12-30 2001-12-04 Depuy Orthopaedics, Inc Tissue reactive adhesive compositions
EP1016377B1 (en) 1998-12-30 2006-04-26 Ethicon Inc. Suture locking device
US6200347B1 (en) * 1999-01-05 2001-03-13 Lifenet Composite bone graft, method of making and using same
US6093201A (en) 1999-01-19 2000-07-25 Ethicon, Inc. Biocompatible absorbable polymer plating system for tissue fixation
US6547823B2 (en) 1999-01-22 2003-04-15 Osteotech, Inc. Intervertebral implant
US6251143B1 (en) 1999-06-04 2001-06-26 Depuy Orthopaedics, Inc. Cartilage repair unit
US6288043B1 (en) 1999-06-18 2001-09-11 Orquest, Inc. Injectable hyaluronate-sulfated polysaccharide conjugates
US6964685B2 (en) * 1999-06-22 2005-11-15 The Brigham And Women's Hospital, Inc. Biologic replacement for fibrin clot
US6355699B1 (en) 1999-06-30 2002-03-12 Ethicon, Inc. Process for manufacturing biomedical foams
US6333029B1 (en) 1999-06-30 2001-12-25 Ethicon, Inc. Porous tissue scaffoldings for the repair of regeneration of tissue
US6458383B2 (en) * 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
US6652872B2 (en) * 1999-07-06 2003-11-25 Ramat At Tel Aviv University Ltd. Scaffold formed of tissue treated to eliminate cellular and cytosolic elements
US6447517B1 (en) * 1999-07-23 2002-09-10 Ethicon, Inc. Instrument for inserting graft fixation device
US6364884B1 (en) 1999-07-23 2002-04-02 Ethicon, Inc. Method of securing a graft using a graft fixation device
US6179840B1 (en) 1999-07-23 2001-01-30 Ethicon, Inc. Graft fixation device and method
US7214232B2 (en) * 1999-07-23 2007-05-08 Ethicon, Inc. Graft fixation device
US6497707B1 (en) * 1999-07-23 2002-12-24 Ethicon, Inc. Graft fixation device combination
ES2234642T3 (en) * 1999-07-28 2005-07-01 Davol Inc PROTESIS FOR HERNIAS.
US6290711B1 (en) * 1999-08-13 2001-09-18 Innovasive Devices, Inc. Connector device and method for surgically joining and securing flexible tissue repair members
US6319258B1 (en) 1999-09-29 2001-11-20 Ethicon, Inc. Absorbable rivet/pin applier for use in surgical procedures
US6273893B1 (en) 1999-11-10 2001-08-14 Ethicon, Inc. Absorbable rivet/pin applier for use in surgical procedures
US7153312B1 (en) 1999-12-02 2006-12-26 Smith & Nephew Inc. Closure device and method for tissue repair
EP1233707B1 (en) 1999-12-03 2007-08-08 The University Of Leeds Repair of damaged tissue
US6371958B1 (en) 2000-03-02 2002-04-16 Ethicon, Inc. Scaffold fixation device for use in articular cartilage repair
US6626945B2 (en) * 2000-03-14 2003-09-30 Chondrosite, Llc Cartilage repair plug
US6520964B2 (en) * 2000-05-01 2003-02-18 Std Manufacturing, Inc. System and method for joint resurface repair
AU2001261595A1 (en) * 2000-05-22 2001-12-03 Arthur C. Coffey Combination sis and vacuum bandage and method
US6661506B2 (en) * 2000-08-24 2003-12-09 Og Technologies, Inc. Engine bearing inspection system
EP1320390A2 (en) * 2000-09-18 2003-06-25 Organogenesis Inc. Bioengineered flat sheet graft prosthesis and its use
US6812221B2 (en) * 2000-11-21 2004-11-02 The Texas A&M University System FGF-affinity chromatography
US7192445B2 (en) * 2000-12-06 2007-03-20 Astra Tech Ab Medical prosthetic devices and implants having improved biocompatibility
US7166133B2 (en) * 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
US20050249772A1 (en) * 2004-05-04 2005-11-10 Prasanna Malaviya Hybrid biologic-synthetic bioabsorbable scaffolds
US7569233B2 (en) * 2004-05-04 2009-08-04 Depuy Products, Inc. Hybrid biologic-synthetic bioabsorbable scaffolds
EP1593400A1 (en) 2004-05-04 2005-11-09 Depuy Products, Inc. Hybrid biologic-synthetic bioabsorbable scaffolds

Patent Citations (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3272204A (en) * 1965-09-22 1966-09-13 Ethicon Inc Absorbable collagen prosthetic implant with non-absorbable reinforcing strands
US4956179A (en) * 1971-11-01 1990-09-11 Astra Lakemedel Aktiebolag Antibacterial combination of penicillin and cephalosporin
US4141087A (en) * 1977-01-19 1979-02-27 Ethicon, Inc. Isomorphic copolyoxalates and sutures thereof
US4206511A (en) * 1977-05-18 1980-06-03 Mannesmann Aktiengesellschaft Locating a welding seam
US4105034A (en) * 1977-06-10 1978-08-08 Ethicon, Inc. Poly(alkylene oxalate) absorbable coating for sutures
US4140678A (en) * 1977-06-13 1979-02-20 Ethicon, Inc. Synthetic absorbable surgical devices of poly(alkylene oxalates)
US4205399A (en) * 1977-06-13 1980-06-03 Ethicon, Inc. Synthetic absorbable surgical devices of poly(alkylene oxalates)
US4741330A (en) * 1983-05-19 1988-05-03 Hayhurst John O Method and apparatus for anchoring and manipulating cartilage
US4610397A (en) * 1983-10-27 1986-09-09 Urschel Laboratories Incorporated Comminuting equipment
US4750492A (en) * 1985-02-27 1988-06-14 Richards Medical Company Absorbable suture apparatus, method and installer
US4669473A (en) * 1985-09-06 1987-06-02 Acufex Microsurgical, Inc. Surgical fastener
US4736372A (en) * 1985-09-13 1988-04-05 Siemens Aktiengesellschaft Method and apparatus of transmission for a digital signal
USRE34021E (en) * 1985-11-18 1992-08-04 Abbott Laboratories Percutaneous fixation of hollow organs
US5736372A (en) * 1986-11-20 1998-04-07 Massachusetts Institute Of Technology Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
US4846835A (en) * 1987-06-15 1989-07-11 Grande Daniel A Technique for healing lesions in cartilage
US5350583A (en) * 1988-03-09 1994-09-27 Terumo Kabushiki Kaisha Cell-penetrable medical material and artificial skin
US5102421A (en) * 1990-06-14 1992-04-07 Wm. E. Anpach, III Suture anchor and method of forming
US5520691A (en) * 1990-11-06 1996-05-28 Branch; Thomas P. Method and apparatus for re-approximating tissue
US5861004A (en) * 1991-11-08 1999-01-19 Kensey Nash Corporation Hemostatic puncture closure system including closure locking means and method of use
US6214048B1 (en) * 1992-02-10 2001-04-10 Matsumoto Dental College Bone substitute product and method of producing the same
US5893888A (en) * 1992-08-07 1999-04-13 Tissue Engineering, Inc. Method and construct for producing graft tissue from extracellular matrix
US6197296B1 (en) * 1993-03-29 2001-03-06 National Heart Research Fund Tissue equivalents
US5447940A (en) * 1993-07-28 1995-09-05 Johnson & Johnson Medical, Inc. Absorbable composite materials for use in the treatment of periodontal disease
US5660225A (en) * 1993-08-30 1997-08-26 Saffran; Bruce Nathan Method of fracture treatment by restraining macromolecules or macromolecular aggregates adjacent to damaged tissues
US5514181A (en) * 1993-09-29 1996-05-07 Johnson & Johnson Medical, Inc. Absorbable structures for ligament and tendon repair
US5595621A (en) * 1993-09-29 1997-01-21 Johnson & Johnson Medical, Inc. Method of making absorbable structures for ligament and tendon repair
US5735897A (en) * 1993-10-19 1998-04-07 Scimed Life Systems, Inc. Intravascular stent pump
US5773577A (en) * 1994-03-03 1998-06-30 Protein Polymer Technologies Products comprising substrates capable of enzymatic cross-linking
US5545178A (en) * 1994-04-29 1996-08-13 Kensey Nash Corporation System for closing a percutaneous puncture formed by a trocar to prevent tissue at the puncture from herniating
US5630824A (en) * 1994-06-01 1997-05-20 Innovasive Devices, Inc. Suture attachment device
US6110212A (en) * 1994-11-15 2000-08-29 Kenton W. Gregory Elastin and elastin-based materials
US5891558A (en) * 1994-11-22 1999-04-06 Tissue Engineering, Inc. Biopolymer foams for use in tissue repair and reconstruction
US5607687A (en) * 1995-03-06 1997-03-04 Ethicon, Inc. Polymer blends containing absorbable polyoxaesters
US5620698A (en) * 1995-03-06 1997-04-15 Ethicon, Inc. Blends of absorbable polyoxaesters containing amines and/or amido groups
US5618552A (en) * 1995-03-06 1997-04-08 Ethicon, Inc. Absorbable polyoxaesters
US5645850A (en) * 1995-03-06 1997-07-08 Ethicon, Inc. Blending containing absorbable polyoxaamides
US5595751A (en) * 1995-03-06 1997-01-21 Ethicon, Inc. Absorbable polyoxaesters containing amines and/or amido groups
US5859150A (en) * 1995-03-06 1999-01-12 Ethicon, Inc. Prepolymers of absorbable polyoxaesters
US5648088A (en) * 1995-03-06 1997-07-15 Ethicon, Inc. Blends of absorbable polyoxaesters containing amines and/or amide groups
US5597579A (en) * 1995-03-06 1997-01-28 Ethicon, Inc. Blends of absorbable polyoxaamides
US6840962B1 (en) * 1995-05-01 2005-01-11 Massachusetts Institute Of Technology Tissue engineered tendons and ligaments
US5855610A (en) * 1995-05-19 1999-01-05 Children's Medical Center Corporation Engineering of strong, pliable tissues
US5725556A (en) * 1995-12-15 1998-03-10 M & R Medical, Inc. Suture locking apparatus
US5626614A (en) * 1995-12-22 1997-05-06 Applied Medical Resources Corporation T-anchor suturing device and method for using same
US5759208A (en) * 1996-02-29 1998-06-02 The Procter & Gamble Company Laundry detergent compositions containing silicone emulsions
US20010002446A1 (en) * 1996-04-05 2001-05-31 Plouhar Pamela L. Tissue graft construct for replacement of cartilaginous structures
US20020034533A1 (en) * 1996-04-16 2002-03-21 Peterson Dale R. Bioerodable polymeric adhesives for tissue repair
US20020031551A1 (en) * 1996-04-16 2002-03-14 Peterson Dale R. Bioerodable polymeric adhesives for tissue repair
US6077989A (en) * 1996-05-28 2000-06-20 Kandel; Rita Resorbable implant biomaterial made of condensed calcium phosphate particles
US5939323A (en) * 1996-05-28 1999-08-17 Brown University Hyaluronan based biodegradable scaffolds for tissue repair
US6387693B2 (en) * 1996-06-04 2002-05-14 Sulzer Orthopedics Ltd. Method for producing cartilage tissue and implants for repairing enchondral and osteochondral defects as well as arrangement for carrying out the method
US6242247B1 (en) * 1996-06-04 2001-06-05 Sulzer Orthopedics Ltd. Method for making cartilage and implants
US6280473B1 (en) * 1996-08-19 2001-08-28 Macropore, Inc. Resorbable, macro-porous, non-collapsing and flexible membrane barrier for skeletal repair and regeneration
US5863551A (en) * 1996-10-16 1999-01-26 Organogel Canada Ltee Implantable polymer hydrogel for therapeutic uses
US6358284B1 (en) * 1996-12-10 2002-03-19 Med Institute, Inc. Tubular grafts from purified submucosa
US6280474B1 (en) * 1997-01-09 2001-08-28 Neucoll, Inc. Devices for tissue repair and methods for preparation and use thereof
US5866165A (en) * 1997-01-15 1999-02-02 Orquest, Inc. Collagen-polysaccharide matrix for bone and cartilage repair
US6270530B1 (en) * 1997-05-01 2001-08-07 C.R. Bard, Inc. Prosthetic repair fabric
US6034140A (en) * 1997-06-17 2000-03-07 Fziomed, Inc. Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
US6869938B1 (en) * 1997-06-17 2005-03-22 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use in reducing adhesions
US5906997A (en) * 1997-06-17 1999-05-25 Fzio Med, Inc. Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
US6017301A (en) * 1997-06-17 2000-01-25 Fziomed, Inc. Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
US6692499B2 (en) * 1997-07-02 2004-02-17 Linvatec Biomaterials Oy Surgical fastener for tissue treatment
US6010525A (en) * 1997-08-01 2000-01-04 Peter M. Bonutti Method and apparatus for securing a suture
US6264702B1 (en) * 1997-08-01 2001-07-24 Sofradim Production Composite prosthesis for preventing post-surgical adhesions
US6267957B1 (en) * 1998-01-20 2001-07-31 Howard Green Attaching agents to tissue with transglutaminase and a transglutaminase substrate
US5899939A (en) * 1998-01-21 1999-05-04 Osteotech, Inc. Bone-derived implant for load-supporting applications
US6265333B1 (en) * 1998-06-02 2001-07-24 Board Of Regents, University Of Nebraska-Lincoln Delamination resistant composites prepared by small diameter fiber reinforcement at ply interfaces
US6572650B1 (en) * 1998-06-05 2003-06-03 Organogenesis Inc. Bioengineered vascular graft support prostheses
US6066160A (en) * 1998-11-23 2000-05-23 Quickie Llc Passive knotless suture terminator for use in minimally invasive surgery and to facilitate standard tissue securing
US6517564B1 (en) * 1999-02-02 2003-02-11 Arthrex, Inc. Bioabsorbable tissue tack with oval-shaped head and method of tissue fixation using same
US6440444B2 (en) * 1999-02-23 2002-08-27 Osteotech, Inc. Load bearing osteoimplant and method of repairing bone using the same
US6258124B1 (en) * 1999-05-10 2001-07-10 C. R. Bard, Inc. Prosthetic repair fabric
US20020095157A1 (en) * 1999-07-23 2002-07-18 Bowman Steven M. Graft fixation device combination
US6436110B2 (en) * 1999-07-23 2002-08-20 Ethicon, Inc. Method of securing a graft using a graft fixation device
US6423073B2 (en) * 1999-07-23 2002-07-23 Ethicon, Inc. Instrument for inserting graft fixation device
US6402766B2 (en) * 1999-07-23 2002-06-11 Ethicon, Inc. Graft fixation device combination
US20020052628A1 (en) * 1999-07-23 2002-05-02 Bowman Steven M. Graft fixation device and method
US6592623B1 (en) * 1999-08-31 2003-07-15 Virginia Commonwealth University Intellectual Property Foundation Engineered muscle
US6373221B2 (en) * 1999-12-27 2002-04-16 Kabushiki Kaisha Toyoda Jidoshokki Seisakusho Charger coupling
US6508821B1 (en) * 2000-01-28 2003-01-21 Depuy Orthopaedics, Inc. Soft tissue repair material fixation apparatus and method
US6566345B2 (en) * 2000-04-28 2003-05-20 Fziomed, Inc. Polyacid/polyalkylene oxide foams and gels and methods for their delivery
US20030023316A1 (en) * 2000-08-04 2003-01-30 Brown Laura Jean Hybrid biologic-synthetic bioabsorable scaffolds
US20020038151A1 (en) * 2000-08-04 2002-03-28 Plouhar Pamela L. Reinforced small intestinal submucosa (SIS)
US20040059431A1 (en) * 2000-08-04 2004-03-25 Plouhar Pamela L. Reinforced small intestinal submucosa
US20030014126A1 (en) * 2001-06-28 2003-01-16 Patel Umesh H. Graft prosthesis devices containing renal capsule collagen
US20030021827A1 (en) * 2001-07-16 2003-01-30 Prasanna Malaviya Hybrid biologic/synthetic porous extracellular matrix scaffolds
US20030078617A1 (en) * 2001-07-16 2003-04-24 Schwartz Herbert E. Unitary surgical device and method
US20030049299A1 (en) * 2001-07-16 2003-03-13 Prasanna Malaviya Porous delivery scaffold and method
US20030044444A1 (en) * 2001-07-16 2003-03-06 Prasanna Malaviya Porous extracellular matrix scaffold and method
US20030036801A1 (en) * 2001-07-16 2003-02-20 Schwartz Herbert E. Cartilage repair apparatus and method
US20030036797A1 (en) * 2001-07-16 2003-02-20 Prasanna Malaviya Meniscus regeneration device and method
US20040143344A1 (en) * 2001-07-16 2004-07-22 Prasanna Malaviya Implantable tissue repair device and method
US20030033022A1 (en) * 2001-07-16 2003-02-13 Plouhar Pamela Lynn Cartilage repair and regeneration device and method
US20050027307A1 (en) * 2001-07-16 2005-02-03 Schwartz Herbert Eugene Unitary surgical device and method
US20030032961A1 (en) * 2001-07-16 2003-02-13 Pelo Mark Joseph Devices from naturally occurring biologically derived materials
US6989034B2 (en) * 2002-05-31 2006-01-24 Ethicon, Inc. Attachment of absorbable tissue scaffolds to fixation devices
US20040166169A1 (en) * 2002-07-15 2004-08-26 Prasanna Malaviya Porous extracellular matrix scaffold and method

Cited By (348)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8016867B2 (en) 1999-07-23 2011-09-13 Depuy Mitek, Inc. Graft fixation device and method
US20070162055A1 (en) * 1999-07-23 2007-07-12 Bowman Steven M Graft fixation device combination
US8449561B2 (en) 1999-07-23 2013-05-28 Depuy Mitek, Llc Graft fixation device combination
US20050119756A1 (en) * 2000-04-07 2005-06-02 Tecres S.P.A. Disposable articulated spacing device for surgical treatment of joints of the human body
US20040054417A1 (en) * 2000-04-07 2004-03-18 Renzo Soffiati Disposable articulated spacing device for surgical treatment of joints of the human body
US7601176B2 (en) 2000-04-07 2009-10-13 Tecres S.P.A. Disposable articulated spacing device for surgical treatment of joints of the human body
US20070129811A1 (en) * 2000-08-04 2007-06-07 Plouhar Pamela L Reinforced small intestinal submucosa
US20040059431A1 (en) * 2000-08-04 2004-03-25 Plouhar Pamela L. Reinforced small intestinal submucosa
US8366787B2 (en) 2000-08-04 2013-02-05 Depuy Products, Inc. Hybrid biologic-synthetic bioabsorbable scaffolds
US20030023316A1 (en) * 2000-08-04 2003-01-30 Brown Laura Jean Hybrid biologic-synthetic bioabsorable scaffolds
US7799089B2 (en) 2000-08-04 2010-09-21 Depuy Orthopaedics, Inc. Reinforced small intestinal submucosa
US8691259B2 (en) 2000-12-21 2014-04-08 Depuy Mitek, Llc Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US7819918B2 (en) * 2001-07-16 2010-10-26 Depuy Products, Inc. Implantable tissue repair device
US20040143344A1 (en) * 2001-07-16 2004-07-22 Prasanna Malaviya Implantable tissue repair device and method
US20030033022A1 (en) * 2001-07-16 2003-02-13 Plouhar Pamela Lynn Cartilage repair and regeneration device and method
US8012205B2 (en) * 2001-07-16 2011-09-06 Depuy Products, Inc. Cartilage repair and regeneration device
US20030036797A1 (en) * 2001-07-16 2003-02-20 Prasanna Malaviya Meniscus regeneration device and method
US20040220574A1 (en) * 2001-07-16 2004-11-04 Pelo Mark Joseph Device from naturally occuring biologically derived materials
US8337537B2 (en) 2001-07-16 2012-12-25 Depuy Products, Inc. Device from naturally occurring biologically derived materials
US8025896B2 (en) 2001-07-16 2011-09-27 Depuy Products, Inc. Porous extracellular matrix scaffold and method
US7914808B2 (en) 2001-07-16 2011-03-29 Depuy Products, Inc. Hybrid biologic/synthetic porous extracellular matrix scaffolds
US20050027307A1 (en) * 2001-07-16 2005-02-03 Schwartz Herbert Eugene Unitary surgical device and method
US20030078617A1 (en) * 2001-07-16 2003-04-24 Schwartz Herbert E. Unitary surgical device and method
US8092529B2 (en) 2001-07-16 2012-01-10 Depuy Products, Inc. Meniscus regeneration device
US20030044444A1 (en) * 2001-07-16 2003-03-06 Prasanna Malaviya Porous extracellular matrix scaffold and method
US20050090139A1 (en) * 2002-03-28 2005-04-28 Rowland White Contact
US20090101599A1 (en) * 2002-05-03 2009-04-23 Hanuman, L.L.C. Methods And Apparatus For Isolating Platelets From Blood
US8950586B2 (en) 2002-05-03 2015-02-10 Hanuman Llc Methods and apparatus for isolating platelets from blood
US7837884B2 (en) 2002-05-03 2010-11-23 Hanuman, Llc Methods and apparatus for isolating platelets from blood
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US8187477B2 (en) 2002-05-03 2012-05-29 Hanuman, Llc Methods and apparatus for isolating platelets from blood
US20070034579A1 (en) * 2002-05-03 2007-02-15 Randel Dorian Methods and apparatus for isolating platelets from blood
US7914689B2 (en) 2002-05-24 2011-03-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US7780860B2 (en) 2002-05-24 2010-08-24 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9114334B2 (en) 2002-05-24 2015-08-25 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US20060273050A1 (en) * 2002-05-24 2006-12-07 Higgins Joel C Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20110168193A1 (en) * 2002-05-24 2011-07-14 Biomet Biologics, Llc Apparatus and Method for Separating and Concentrating Fluids Containing Multiple Components
US8048321B2 (en) 2002-05-24 2011-11-01 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8808551B2 (en) 2002-05-24 2014-08-19 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8603346B2 (en) 2002-05-24 2013-12-10 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8163184B2 (en) 2002-05-24 2012-04-24 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10393728B2 (en) 2002-05-24 2019-08-27 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8062534B2 (en) 2002-05-24 2011-11-22 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20110056893A1 (en) * 2002-05-24 2011-03-10 Biomet Biologics, LLC. Apparatus and Method for Separating and Concentrating Fluids Containing Multiple Components
US20080217264A1 (en) * 2002-05-24 2008-09-11 Biomet Manufacturing Corp. Apparatus And Method For Separating And Concentrating Fluids Containing Multiple Components
US20080217265A1 (en) * 2002-05-24 2008-09-11 Biomet Manufacturing Corp. Apparatus And Method for Separating And Concentrating Fluids Containing Multiple Components
US9897589B2 (en) 2002-05-24 2018-02-20 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10183042B2 (en) 2002-05-24 2019-01-22 Biomet Manufacturing, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20040166169A1 (en) * 2002-07-15 2004-08-26 Prasanna Malaviya Porous extracellular matrix scaffold and method
US7820638B2 (en) * 2002-08-09 2010-10-26 Arthrex, Inc. Method of applying hyaluronic acid to implant or graft to enhance lubricity and cellular density
US20040180822A1 (en) * 2002-08-09 2004-09-16 Grafton R. Donald Method of applying hyaluronic acid to implant or graft to enhance lubricity and cellular density
US20110009963A1 (en) * 2002-10-18 2011-01-13 Depuy Mitek, Inc. Biocompatible scaffold for ligament or tendon repair
US7824701B2 (en) 2002-10-18 2010-11-02 Ethicon, Inc. Biocompatible scaffold for ligament or tendon repair
US9511171B2 (en) 2002-10-18 2016-12-06 Depuy Mitek, Llc Biocompatible scaffolds with tissue fragments
US20110091517A1 (en) * 2002-10-18 2011-04-21 Depuy Mitek, Inc. Biocompatible scaffolds with tissue fragments
US10603408B2 (en) 2002-10-18 2020-03-31 DePuy Synthes Products, Inc. Biocompatible scaffolds with tissue fragments
US8637066B2 (en) 2002-10-18 2014-01-28 Depuy Mitek, Llc Biocompatible scaffold for ligament or tendon repair
US8895045B2 (en) 2003-03-07 2014-11-25 Depuy Mitek, Llc Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
US9486558B2 (en) 2003-03-27 2016-11-08 Locate Therapeutics Limited Porous matrix
US20060263335A1 (en) * 2003-03-27 2006-11-23 Regentec Ltd. Porous matrix
US10232087B2 (en) 2003-03-27 2019-03-19 Locate Therapeutics Limited Porous matrix
US20080274157A1 (en) * 2003-04-29 2008-11-06 Gordana Vunjak-Novakovic Cartilage implant plug with fibrin glue and method for implantation
USRE43258E1 (en) 2003-04-29 2012-03-20 Musculoskeletal Transplant Foundation Glue for cartilage repair
US20060210643A1 (en) * 2003-04-29 2006-09-21 Truncale Katherine A G Cartilage repair mixture containing allograft chondrocytes
USRE42208E1 (en) 2003-04-29 2011-03-08 Musculoskeletal Transplant Foundation Glue for cartilage repair
US20080133008A1 (en) * 2003-04-29 2008-06-05 Muscuoskeletal Transplant Foundation Cartilage repair mixture containing allograft chondrocytes
US20090291112A1 (en) * 2003-05-16 2009-11-26 Truncale Katherine G Allograft osteochondral plug combined with cartilage particle mixture
US8221500B2 (en) 2003-05-16 2012-07-17 Musculoskeletal Transplant Foundation Cartilage allograft plug
US20040230303A1 (en) * 2003-05-16 2004-11-18 Gomes Katherine A. Cartilage allograft plug
US20050251268A1 (en) * 2003-05-16 2005-11-10 Musculoskeletal Transplant Foundation Cartilage allograft plug
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US9211362B2 (en) 2003-06-30 2015-12-15 Depuy Mitek, Llc Scaffold for connective tissue repair
US8226715B2 (en) 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
US20040267362A1 (en) * 2003-06-30 2004-12-30 Julia Hwang Scaffold for connective tissue repair
US20050038520A1 (en) * 2003-08-11 2005-02-17 Francois Binette Method and apparatus for resurfacing an articular surface
US10583220B2 (en) 2003-08-11 2020-03-10 DePuy Synthes Products, Inc. Method and apparatus for resurfacing an articular surface
US8137702B2 (en) 2003-11-26 2012-03-20 Depuy Mitek, Inc. Conformable tissue repair implant capable of injection delivery
US8496970B2 (en) 2003-11-26 2013-07-30 Depuy Mitek, Llc Conformable tissue repair implant capable of injection delivery
US20080071385A1 (en) * 2003-11-26 2008-03-20 Depuy Mitek, Inc. Conformable tissue repair implant capable of injection delivery
US7875296B2 (en) 2003-11-26 2011-01-25 Depuy Mitek, Inc. Conformable tissue repair implant capable of injection delivery
US20110097381A1 (en) * 2003-11-26 2011-04-28 Depuy Mitek, Inc. Conformable tissue repair implant capable of injection delivery
US20050125077A1 (en) * 2003-12-05 2005-06-09 Harmon Alexander M. Viable tissue repair implants and methods of use
US7901461B2 (en) 2003-12-05 2011-03-08 Ethicon, Inc. Viable tissue repair implants and methods of use
US8641775B2 (en) * 2003-12-05 2014-02-04 Depuy Mitek, Llc Viable tissue repair implants and methods of use
US20110177134A1 (en) * 2003-12-05 2011-07-21 Depuy Mitek, Inc. Viable Tissue Repair Implants and Methods of Use
US20050125073A1 (en) * 2003-12-08 2005-06-09 Orban Janine M. Implant device for cartilage regeneration in load bearing articulation regions
US7666230B2 (en) 2003-12-08 2010-02-23 Depuy Products, Inc. Implant device for cartilage regeneration in load bearing articulation regions
US11395865B2 (en) 2004-02-09 2022-07-26 DePuy Synthes Products, Inc. Scaffolds with viable tissue
US8221454B2 (en) 2004-02-20 2012-07-17 Biomet Sports Medicine, Llc Apparatus for performing meniscus repair
US20050222687A1 (en) * 2004-04-02 2005-10-06 Gordana Vunjak-Novakovic Cartilage implant assembly and method for implantation
US8137686B2 (en) 2004-04-20 2012-03-20 Depuy Mitek, Inc. Nonwoven tissue scaffold
US8221780B2 (en) 2004-04-20 2012-07-17 Depuy Mitek, Inc. Nonwoven tissue scaffold
US20050249772A1 (en) * 2004-05-04 2005-11-10 Prasanna Malaviya Hybrid biologic-synthetic bioabsorbable scaffolds
US20050249771A1 (en) * 2004-05-04 2005-11-10 Prasanna Malaviya Hybrid biologic-synthetic bioabsorbable scaffolds
US8292968B2 (en) 2004-10-12 2012-10-23 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US20090319045A1 (en) * 2004-10-12 2009-12-24 Truncale Katherine G Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US8574238B2 (en) 2004-10-29 2013-11-05 Depuy Mitek, Llc Instruments, kit and method for suture management
US7857851B2 (en) 2004-10-29 2010-12-28 Depuy Products, Inc. Implant system with sizing templates
US20060211953A1 (en) * 2004-10-29 2006-09-21 Zannis Anthony D Coordinate instrument set
EP1652473A1 (en) 2004-10-29 2006-05-03 DePuy Products, Inc. Implant system with sizing templates
US20060128296A1 (en) * 2004-10-29 2006-06-15 Schwan Wade E Intestine processing device and associated method
US20060095054A1 (en) * 2004-10-29 2006-05-04 Zannis Anthony D Instruments, kit and method for suture management
US7785332B2 (en) 2004-10-29 2010-08-31 Depuy Products, Inc. Method of delivering therapeutic implant
US20060095053A1 (en) * 2004-10-29 2006-05-04 Zannis Anthony D Method of delivering therapeutic implant
EP1652484A1 (en) 2004-10-29 2006-05-03 DePuy Products, Inc. Instruments, kit and method for suture managment
US9113954B2 (en) 2004-10-29 2015-08-25 DePuy Synthes Products, Inc. Coordinate instrument set
US8137382B2 (en) 2004-11-05 2012-03-20 Biomet Sports Medicine, Llc Method and apparatus for coupling anatomical features
US11109857B2 (en) 2004-11-05 2021-09-07 Biomet Sports Medicine, Llc Soft tissue repair device and method
US9801708B2 (en) 2004-11-05 2017-10-31 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US8128658B2 (en) 2004-11-05 2012-03-06 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to bone
US8303604B2 (en) 2004-11-05 2012-11-06 Biomet Sports Medicine, Llc Soft tissue repair device and method
US20060190042A1 (en) * 2004-11-05 2006-08-24 Arthrotek, Inc. Tissue repair assembly
US9572655B2 (en) 2004-11-05 2017-02-21 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US8118836B2 (en) 2004-11-05 2012-02-21 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US9504460B2 (en) 2004-11-05 2016-11-29 Biomet Sports Medicine, LLC. Soft tissue repair device and method
US10265064B2 (en) 2004-11-05 2019-04-23 Biomet Sports Medicine, Llc Soft tissue repair device and method
US8551140B2 (en) 2004-11-05 2013-10-08 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to bone
US8840645B2 (en) 2004-11-05 2014-09-23 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US8317825B2 (en) 2004-11-09 2012-11-27 Biomet Sports Medicine, Llc Soft tissue conduit device and method
US8998949B2 (en) 2004-11-09 2015-04-07 Biomet Sports Medicine, Llc Soft tissue conduit device
US7914539B2 (en) 2004-11-09 2011-03-29 Biomet Sports Medicine, Llc Tissue fixation device
US20060189993A1 (en) * 2004-11-09 2006-08-24 Arthrotek, Inc. Soft tissue conduit device
US8034090B2 (en) 2004-11-09 2011-10-11 Biomet Sports Medicine, Llc Tissue fixation device
US20060135638A1 (en) * 2004-12-22 2006-06-22 Pedrozo Hugo A Method for organizing the assembly of collagen fibers and compositions formed therefrom
US8808309B2 (en) 2005-02-07 2014-08-19 Ivy Sports Medicine, Llc System and method for all-inside suture fixation for implant attachment and soft tissue repair
US8128640B2 (en) 2005-02-07 2012-03-06 Ivy Sports Medicine LLC System and method for all-inside suture fixation for implant attachment and soft tissue repair
US9402616B2 (en) 2005-02-07 2016-08-02 Ivy Sports Medicine, Llc System and method for all-inside suture fixation for implant attachment and soft tissue repair
US9949732B2 (en) 2005-02-07 2018-04-24 Ivy Sports Medicine, Llc System and method for all-inside suture fixation for implant attachment and soft tissue repair
US10548590B2 (en) 2005-02-07 2020-02-04 Ivy Sports Medicine, Llc System and method for all-inside suture fixation for implant attachment and soft tissue repair
US20060178680A1 (en) * 2005-02-07 2006-08-10 Regen Biologics, Inc. System and method for all-inside suture fixation for implant attachment and soft tissue repair
US7531190B2 (en) 2005-05-25 2009-05-12 Biomet Manufacturing Corp. Porous ceramic structure containing biologics
US20060271201A1 (en) * 2005-05-25 2006-11-30 Biomet Manufacturing Corp. Porous ceramic structure containing biologics
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
US9701940B2 (en) 2005-09-19 2017-07-11 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
US10687803B2 (en) 2006-02-03 2020-06-23 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US8652171B2 (en) 2006-02-03 2014-02-18 Biomet Sports Medicine, Llc Method and apparatus for soft tissue fixation
US11589859B2 (en) 2006-02-03 2023-02-28 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to bone
US8361113B2 (en) 2006-02-03 2013-01-29 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US11617572B2 (en) 2006-02-03 2023-04-04 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US11471147B2 (en) 2006-02-03 2022-10-18 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US8409253B2 (en) 2006-02-03 2013-04-02 Biomet Sports Medicine, Llc Soft tissue repair assembly and associated method
US11446019B2 (en) 2006-02-03 2022-09-20 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US11723648B2 (en) 2006-02-03 2023-08-15 Biomet Sports Medicine, Llc Method and apparatus for soft tissue fixation
US8088130B2 (en) 2006-02-03 2012-01-03 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US11317907B2 (en) 2006-02-03 2022-05-03 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable loop
US11311287B2 (en) 2006-02-03 2022-04-26 Biomet Sports Medicine, Llc Method for tissue fixation
US11284884B2 (en) 2006-02-03 2022-03-29 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US11259792B2 (en) 2006-02-03 2022-03-01 Biomet Sports Medicine, Llc Method and apparatus for coupling anatomical features
US11116495B2 (en) 2006-02-03 2021-09-14 Biomet Sports Medicine, Llc Soft tissue repair assembly and associated method
US9532777B2 (en) 2006-02-03 2017-01-03 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US8574235B2 (en) 2006-02-03 2013-11-05 Biomet Sports Medicine, Llc Method for trochanteric reattachment
US8932331B2 (en) 2006-02-03 2015-01-13 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to bone
US11065103B2 (en) 2006-02-03 2021-07-20 Biomet Sports Medicine, Llc Method and apparatus for fixation of an ACL graft
US8597327B2 (en) 2006-02-03 2013-12-03 Biomet Manufacturing, Llc Method and apparatus for sternal closure
US11039826B2 (en) 2006-02-03 2021-06-22 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable loop
US7909851B2 (en) 2006-02-03 2011-03-22 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US8608777B2 (en) 2006-02-03 2013-12-17 Biomet Sports Medicine Method and apparatus for coupling soft tissue to a bone
US8632569B2 (en) 2006-02-03 2014-01-21 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US7905903B2 (en) 2006-02-03 2011-03-15 Biomet Sports Medicine, Llc Method for tissue fixation
US7905904B2 (en) 2006-02-03 2011-03-15 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US9510819B2 (en) 2006-02-03 2016-12-06 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US8652172B2 (en) 2006-02-03 2014-02-18 Biomet Sports Medicine, Llc Flexible anchors for tissue fixation
US10987099B2 (en) 2006-02-03 2021-04-27 Biomet Sports Medicine, Llc Method for tissue fixation
US10973507B2 (en) 2006-02-03 2021-04-13 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US10932770B2 (en) 2006-02-03 2021-03-02 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US8721684B2 (en) 2006-02-03 2014-05-13 Biomet Sports Medicine, Llc Method and apparatus for coupling anatomical features
US10729421B2 (en) 2006-02-03 2020-08-04 Biomet Sports Medicine, Llc Method and apparatus for soft tissue fixation
US8771316B2 (en) 2006-02-03 2014-07-08 Biomet Sports Medicine, Llc Method and apparatus for coupling anatomical features
US9538998B2 (en) 2006-02-03 2017-01-10 Biomet Sports Medicine, Llc Method and apparatus for fracture fixation
US10729430B2 (en) 2006-02-03 2020-08-04 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US10716557B2 (en) 2006-02-03 2020-07-21 Biomet Sports Medicine, Llc Method and apparatus for coupling anatomical features
US10702259B2 (en) 2006-02-03 2020-07-07 Biomet Sports Medicine, Llc Soft tissue repair assembly and associated method
US10695052B2 (en) 2006-02-03 2020-06-30 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US9510821B2 (en) 2006-02-03 2016-12-06 Biomet Sports Medicine, Llc Method and apparatus for coupling anatomical features
US7857830B2 (en) 2006-02-03 2010-12-28 Biomet Sports Medicine, Llc Soft tissue repair and conduit device
US10675073B2 (en) 2006-02-03 2020-06-09 Biomet Sports Medicine, Llc Method and apparatus for sternal closure
US10542967B2 (en) 2006-02-03 2020-01-28 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US8337525B2 (en) 2006-02-03 2012-12-25 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US11730464B2 (en) 2006-02-03 2023-08-22 Biomet Sports Medicine, Llc Soft tissue repair assembly and associated method
US8936621B2 (en) 2006-02-03 2015-01-20 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable loop
US11786236B2 (en) 2006-02-03 2023-10-17 Biomet Sports Medicine, Llc Method and apparatus for coupling anatomical features
US8968364B2 (en) 2006-02-03 2015-03-03 Biomet Sports Medicine, Llc Method and apparatus for fixation of an ACL graft
US10595851B2 (en) 2006-02-03 2020-03-24 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US8273106B2 (en) 2006-02-03 2012-09-25 Biomet Sports Medicine, Llc Soft tissue repair and conduit device
US9005287B2 (en) 2006-02-03 2015-04-14 Biomet Sports Medicine, Llc Method for bone reattachment
US11819205B2 (en) 2006-02-03 2023-11-21 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US10603029B2 (en) 2006-02-03 2020-03-31 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to bone
US10517587B2 (en) 2006-02-03 2019-12-31 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable loop
US10441264B2 (en) 2006-02-03 2019-10-15 Biomet Sports Medicine, Llc Soft tissue repair assembly and associated method
US10398428B2 (en) 2006-02-03 2019-09-03 Biomet Sports Medicine, Llc Method and apparatus for coupling anatomical features
US10321906B2 (en) 2006-02-03 2019-06-18 Biomet Sports Medicine, Llc Method for tissue fixation
US10251637B2 (en) 2006-02-03 2019-04-09 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US9149267B2 (en) 2006-02-03 2015-10-06 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US9173651B2 (en) 2006-02-03 2015-11-03 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US7749250B2 (en) 2006-02-03 2010-07-06 Biomet Sports Medicine, Llc Soft tissue repair assembly and associated method
US10154837B2 (en) 2006-02-03 2018-12-18 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US10098629B2 (en) 2006-02-03 2018-10-16 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US10092288B2 (en) 2006-02-03 2018-10-09 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US10022118B2 (en) 2006-02-03 2018-07-17 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US9271713B2 (en) 2006-02-03 2016-03-01 Biomet Sports Medicine, Llc Method and apparatus for tensioning a suture
US10004588B2 (en) 2006-02-03 2018-06-26 Biomet Sports Medicine, Llc Method and apparatus for fixation of an ACL graft
US10004489B2 (en) 2006-02-03 2018-06-26 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US9993241B2 (en) 2006-02-03 2018-06-12 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable loop
US11896210B2 (en) 2006-02-03 2024-02-13 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US9801620B2 (en) 2006-02-03 2017-10-31 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to bone
US8298262B2 (en) 2006-02-03 2012-10-30 Biomet Sports Medicine, Llc Method for tissue fixation
US9763656B2 (en) 2006-02-03 2017-09-19 Biomet Sports Medicine, Llc Method and apparatus for soft tissue fixation
US9498204B2 (en) 2006-02-03 2016-11-22 Biomet Sports Medicine, Llc Method and apparatus for coupling anatomical features
US9402621B2 (en) 2006-02-03 2016-08-02 Biomet Sports Medicine, LLC. Method for tissue fixation
US8292921B2 (en) 2006-02-03 2012-10-23 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US9414833B2 (en) 2006-02-03 2016-08-16 Biomet Sports Medicine, Llc Soft tissue repair assembly and associated method
US9642661B2 (en) 2006-02-03 2017-05-09 Biomet Sports Medicine, Llc Method and Apparatus for Sternal Closure
US9622736B2 (en) 2006-02-03 2017-04-18 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US9468433B2 (en) 2006-02-03 2016-10-18 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable loop
US9603591B2 (en) 2006-02-03 2017-03-28 Biomet Sports Medicine, Llc Flexible anchors for tissue fixation
US9561025B2 (en) 2006-02-03 2017-02-07 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US9492158B2 (en) 2006-02-03 2016-11-15 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20070276191A1 (en) * 2006-05-26 2007-11-29 Sean Selover Illuminated surgical access system including a surgical access device and integrated light emitter
US8251998B2 (en) 2006-08-16 2012-08-28 Biomet Sports Medicine, Llc Chondral defect repair
US8777956B2 (en) 2006-08-16 2014-07-15 Biomet Sports Medicine, Llc Chondral defect repair
US20080082128A1 (en) * 2006-09-29 2008-04-03 Arthrotek, Inc. Method and apparatus for forming a self-locking adjustable suture loop
US9078644B2 (en) 2006-09-29 2015-07-14 Biomet Sports Medicine, Llc Fracture fixation device
US8672968B2 (en) 2006-09-29 2014-03-18 Biomet Sports Medicine, Llc Method for implanting soft tissue
US10743925B2 (en) 2006-09-29 2020-08-18 Biomet Sports Medicine, Llc Fracture fixation device
US9539003B2 (en) 2006-09-29 2017-01-10 Biomet Sports Medicine, LLC. Method and apparatus for forming a self-locking adjustable loop
US8231654B2 (en) 2006-09-29 2012-07-31 Biomet Sports Medicine, Llc Adjustable knotless loops
US7658751B2 (en) 2006-09-29 2010-02-09 Biomet Sports Medicine, Llc Method for implanting soft tissue
US8672969B2 (en) 2006-09-29 2014-03-18 Biomet Sports Medicine, Llc Fracture fixation device
US9486211B2 (en) 2006-09-29 2016-11-08 Biomet Sports Medicine, Llc Method for implanting soft tissue
US8801783B2 (en) 2006-09-29 2014-08-12 Biomet Sports Medicine, Llc Prosthetic ligament system for knee joint
US10695045B2 (en) 2006-09-29 2020-06-30 Biomet Sports Medicine, Llc Method and apparatus for attaching soft tissue to bone
US10610217B2 (en) 2006-09-29 2020-04-07 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable loop
US10835232B2 (en) 2006-09-29 2020-11-17 Biomet Sports Medicine, Llc Fracture fixation device
US10517714B2 (en) 2006-09-29 2019-12-31 Biomet Sports Medicine, Llc Ligament system for knee joint
US11096684B2 (en) 2006-09-29 2021-08-24 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable loop
US9681940B2 (en) 2006-09-29 2017-06-20 Biomet Sports Medicine, Llc Ligament system for knee joint
US9414925B2 (en) 2006-09-29 2016-08-16 Biomet Manufacturing, Llc Method of implanting a knee prosthesis assembly with a ligament link
US10398430B2 (en) 2006-09-29 2019-09-03 Biomet Sports Medicine, Llc Method for implanting soft tissue
US7959650B2 (en) 2006-09-29 2011-06-14 Biomet Sports Medicine, Llc Adjustable knotless loops
US8562645B2 (en) 2006-09-29 2013-10-22 Biomet Sports Medicine, Llc Method and apparatus for forming a self-locking adjustable loop
US9724090B2 (en) 2006-09-29 2017-08-08 Biomet Manufacturing, Llc Method and apparatus for attaching soft tissue to bone
US11672527B2 (en) 2006-09-29 2023-06-13 Biomet Sports Medicine, Llc Method for implanting soft tissue
US10349931B2 (en) 2006-09-29 2019-07-16 Biomet Sports Medicine, Llc Fracture fixation device
US9788876B2 (en) 2006-09-29 2017-10-17 Biomet Sports Medicine, Llc Fracture fixation device
US8562647B2 (en) 2006-09-29 2013-10-22 Biomet Sports Medicine, Llc Method and apparatus for securing soft tissue to bone
US11259794B2 (en) 2006-09-29 2022-03-01 Biomet Sports Medicine, Llc Method for implanting soft tissue
US9833230B2 (en) 2006-09-29 2017-12-05 Biomet Sports Medicine, Llc Fracture fixation device
US8500818B2 (en) 2006-09-29 2013-08-06 Biomet Manufacturing, Llc Knee prosthesis assembly with ligament link
US11376115B2 (en) 2006-09-29 2022-07-05 Biomet Sports Medicine, Llc Prosthetic ligament system for knee joint
US10004493B2 (en) 2006-09-29 2018-06-26 Biomet Sports Medicine, Llc Method for implanting soft tissue
US9918826B2 (en) 2006-09-29 2018-03-20 Biomet Sports Medicine, Llc Scaffold for spring ligament repair
US20080125863A1 (en) * 2006-11-28 2008-05-29 Mckay William F Implant designs and methods of improving cartilage repair
US20080140094A1 (en) * 2006-12-11 2008-06-12 Schwartz Herbert E Unitary surgical device and method
US7871440B2 (en) 2006-12-11 2011-01-18 Depuy Products, Inc. Unitary surgical device and method
US11612391B2 (en) 2007-01-16 2023-03-28 Biomet Sports Medicine, Llc Soft tissue repair device and associated methods
US8906110B2 (en) 2007-01-24 2014-12-09 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US20080255676A1 (en) * 2007-01-24 2008-10-16 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
US20100015202A1 (en) * 2007-03-06 2010-01-21 Semler Eric J Cancellous construct with support ring for repair of osteochondral defects
US9017381B2 (en) 2007-04-10 2015-04-28 Biomet Sports Medicine, Llc Adjustable knotless loops
US9861351B2 (en) 2007-04-10 2018-01-09 Biomet Sports Medicine, Llc Adjustable knotless loops
US11185320B2 (en) 2007-04-10 2021-11-30 Biomet Sports Medicine, Llc Adjustable knotless loops
US10729423B2 (en) 2007-04-10 2020-08-04 Biomet Sports Medicine, Llc Adjustable knotless loops
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
US9649579B2 (en) 2007-04-12 2017-05-16 Hanuman Llc Buoy suspension fractionation system
US7806276B2 (en) 2007-04-12 2010-10-05 Hanuman, Llc Buoy suspension fractionation system
US20080283474A1 (en) * 2007-04-12 2008-11-20 Biomet Biologics, Llc Buoy suspension fractionation system
US9138664B2 (en) 2007-04-12 2015-09-22 Biomet Biologics, Llc Buoy fractionation system
US8119013B2 (en) 2007-04-12 2012-02-21 Hanuman, Llc Method of separating a selected component from a multiple component material
US8596470B2 (en) 2007-04-12 2013-12-03 Hanuman, Llc Buoy fractionation system
US8137354B2 (en) 2007-04-25 2012-03-20 Biomet Sports Medicine, Llc Localized cartilage defect therapy
US20080269762A1 (en) * 2007-04-25 2008-10-30 Biomet Manufacturing Corp. Method and device for repair of cartilage defects
US20090149893A1 (en) * 2007-12-05 2009-06-11 Semler Eric J Cancellous Bone Implant for Cartilage Repair
US10400017B2 (en) 2008-02-27 2019-09-03 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
US9701728B2 (en) 2008-02-27 2017-07-11 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
US11725031B2 (en) 2008-02-27 2023-08-15 Biomet Manufacturing, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
US9719063B2 (en) 2008-02-29 2017-08-01 Biomet Biologics, Llc System and process for separating a material
US8337711B2 (en) 2008-02-29 2012-12-25 Biomet Biologics, Llc System and process for separating a material
US8801586B2 (en) * 2008-02-29 2014-08-12 Biomet Biologics, Llc System and process for separating a material
US20090221075A1 (en) * 2008-02-29 2009-09-03 Biomet Manufacturing Corp. System And Process For Separating A Material
US20110185560A1 (en) * 2008-08-18 2011-08-04 Qioptiq Photonics Gmbh & Co. Kg Method for producing an objective
US11534159B2 (en) 2008-08-22 2022-12-27 Biomet Sports Medicine, Llc Method and apparatus for coupling soft tissue to a bone
US9314340B2 (en) 2009-02-27 2016-04-19 University of Pittsburgh—of the Commonwealth System of Higher Education Joint bioscaffolds
US20100222882A1 (en) * 2009-02-27 2010-09-02 Badylak Stephen F Joint bioscaffolds
US9848987B2 (en) 2009-02-27 2017-12-26 University of Pittsburgh — Of the Commonwealth System of Higher Education Joint bioscaffolds
US9277999B2 (en) * 2009-02-27 2016-03-08 University of Pittsburgh—of the Commonwealth System of Higher Education Joint bioscaffolds
US8783470B2 (en) 2009-03-06 2014-07-22 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US20100256595A1 (en) * 2009-04-03 2010-10-07 Biomet Biologics, Llc All-In-One Means Of Separating Blood Components
US8992862B2 (en) 2009-04-03 2015-03-31 Biomet Biologics, Llc All-in-one means of separating blood components
US8343227B2 (en) 2009-05-28 2013-01-01 Biomet Manufacturing Corp. Knee prosthesis assembly with ligament link
US8900314B2 (en) 2009-05-28 2014-12-02 Biomet Manufacturing, Llc Method of implanting a prosthetic knee joint assembly
US10149767B2 (en) 2009-05-28 2018-12-11 Biomet Manufacturing, Llc Method of implanting knee prosthesis assembly with ligament link
US20120114755A1 (en) * 2009-06-22 2012-05-10 Mayo Foundation For Medical Education And Research Methods and materials for tissue repair
US9265610B2 (en) 2009-07-10 2016-02-23 Peter Forsell Implantable medical device for lubrication of a synovial joint and method for implanting the device
WO2011005185A1 (en) * 2009-07-10 2011-01-13 Milux Holding S.A. Implantable medical device for lubrication of a synovial joint and method for implanting the device
US20110014705A1 (en) * 2009-07-16 2011-01-20 Biomet Biologics, Llc Method and apparatus for separating biological materials
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US20130060334A1 (en) * 2010-02-25 2013-03-07 Orteq B.V. Meniscus repair assembly and method
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9533090B2 (en) 2010-04-12 2017-01-03 Biomet Biologics, Llc Method and apparatus for separating a material
US9239276B2 (en) 2011-04-19 2016-01-19 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9216078B2 (en) 2011-05-17 2015-12-22 Biomet Sports Medicine, Llc Method and apparatus for tibial fixation of an ACL graft
US8771352B2 (en) 2011-05-17 2014-07-08 Biomet Sports Medicine, Llc Method and apparatus for tibial fixation of an ACL graft
US8506597B2 (en) 2011-10-25 2013-08-13 Biomet Sports Medicine, Llc Method and apparatus for interosseous membrane reconstruction
US9445827B2 (en) 2011-10-25 2016-09-20 Biomet Sports Medicine, Llc Method and apparatus for intraosseous membrane reconstruction
US9357991B2 (en) 2011-11-03 2016-06-07 Biomet Sports Medicine, Llc Method and apparatus for stitching tendons
US10265159B2 (en) 2011-11-03 2019-04-23 Biomet Sports Medicine, Llc Method and apparatus for stitching tendons
US11241305B2 (en) 2011-11-03 2022-02-08 Biomet Sports Medicine, Llc Method and apparatus for stitching tendons
US9381013B2 (en) 2011-11-10 2016-07-05 Biomet Sports Medicine, Llc Method for coupling soft tissue to a bone
US10363028B2 (en) 2011-11-10 2019-07-30 Biomet Sports Medicine, Llc Method for coupling soft tissue to a bone
US11534157B2 (en) 2011-11-10 2022-12-27 Biomet Sports Medicine, Llc Method for coupling soft tissue to a bone
US9314241B2 (en) 2011-11-10 2016-04-19 Biomet Sports Medicine, Llc Apparatus for coupling soft tissue to a bone
US9357992B2 (en) 2011-11-10 2016-06-07 Biomet Sports Medicine, Llc Method for coupling soft tissue to a bone
US9370350B2 (en) 2011-11-10 2016-06-21 Biomet Sports Medicine, Llc Apparatus for coupling soft tissue to a bone
US10368856B2 (en) 2011-11-10 2019-08-06 Biomet Sports Medicine, Llc Apparatus for coupling soft tissue to a bone
US9433407B2 (en) 2012-01-03 2016-09-06 Biomet Manufacturing, Llc Method of implanting a bone fixation assembly
US9259217B2 (en) 2012-01-03 2016-02-16 Biomet Manufacturing, Llc Suture Button
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20150224147A1 (en) * 2013-01-30 2015-08-13 Nu Tech Medical, Inc. Placental Membrane Preparation and Methods of Making and Using Same
US9616093B2 (en) * 2013-01-30 2017-04-11 NuTech Medical, Inc. Placental membrane preparation and methods of making and using same
US9757119B2 (en) 2013-03-08 2017-09-12 Biomet Sports Medicine, Llc Visual aid for identifying suture limbs arthroscopically
US10758221B2 (en) 2013-03-14 2020-09-01 Biomet Sports Medicine, Llc Scaffold for spring ligament repair
US9918827B2 (en) 2013-03-14 2018-03-20 Biomet Sports Medicine, Llc Scaffold for spring ligament repair
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10576130B2 (en) 2013-03-15 2020-03-03 Biomet Manufacturing, Llc Treatment of collagen defects using protein solutions
US10441634B2 (en) 2013-03-15 2019-10-15 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9556243B2 (en) 2013-03-15 2017-01-31 Biomet Biologies, LLC Methods for making cytokine compositions from tissues using non-centrifugal methods
US10136886B2 (en) 2013-12-20 2018-11-27 Biomet Sports Medicine, Llc Knotless soft tissue devices and techniques
US11648004B2 (en) 2013-12-20 2023-05-16 Biomet Sports Medicine, Llc Knotless soft tissue devices and techniques
US10806443B2 (en) 2013-12-20 2020-10-20 Biomet Sports Medicine, Llc Knotless soft tissue devices and techniques
US9615822B2 (en) 2014-05-30 2017-04-11 Biomet Sports Medicine, Llc Insertion tools and method for soft anchor
US9700291B2 (en) 2014-06-03 2017-07-11 Biomet Sports Medicine, Llc Capsule retractor
US11219443B2 (en) 2014-08-22 2022-01-11 Biomet Sports Medicine, Llc Non-sliding soft anchor
US10039543B2 (en) 2014-08-22 2018-08-07 Biomet Sports Medicine, Llc Non-sliding soft anchor
US10743856B2 (en) 2014-08-22 2020-08-18 Biomet Sports Medicine, Llc Non-sliding soft anchor
US11555172B2 (en) 2014-12-02 2023-01-17 Ocugen, Inc. Cell and tissue culture container
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
US9955980B2 (en) 2015-02-24 2018-05-01 Biomet Sports Medicine, Llc Anatomic soft tissue repair
US10912551B2 (en) 2015-03-31 2021-02-09 Biomet Sports Medicine, Llc Suture anchor with soft anchor of electrospun fibers
US11696752B2 (en) 2016-05-26 2023-07-11 Stryker Corporation Systems and methods for all-inside suture fixation for implant attachment and soft tissue repair
US10932769B2 (en) 2016-05-26 2021-03-02 Ivy Sports Medicine, Llc System and method for all-inside suture fixation for implant attachment and soft tissue repair

Also Published As

Publication number Publication date
JP4197160B2 (en) 2008-12-17
JP2004535252A (en) 2004-11-25
EP1416886A4 (en) 2007-04-18
EP1416887A4 (en) 2007-04-18
WO2003007879A3 (en) 2003-08-28
JP2004535243A (en) 2004-11-25
EP1416886A2 (en) 2004-05-12
US20030033022A1 (en) 2003-02-13
WO2003007879A2 (en) 2003-01-30
EP1416887A2 (en) 2004-05-12
AU2002320512B2 (en) 2008-01-31
US8012205B2 (en) 2011-09-06
AU2002316696B2 (en) 2007-08-30
JP4197157B2 (en) 2008-12-17
WO2003007787A2 (en) 2003-01-30
WO2003007787A3 (en) 2003-04-24

Similar Documents

Publication Publication Date Title
AU2002316696B2 (en) Cartilage repair and regeneration scaffold and method
AU2002316696A1 (en) Cartilage repair and regeneration scaffold and method
AU2002320512A1 (en) Cartilage repair and regeneration device and method
US7819918B2 (en) Implantable tissue repair device
US7361195B2 (en) Cartilage repair apparatus and method
US7163563B2 (en) Unitary surgical device and method
US7871440B2 (en) Unitary surgical device and method
AU2005201392B8 (en) Meniscal repair scaffold
US20030021827A1 (en) Hybrid biologic/synthetic porous extracellular matrix scaffolds
AU2002313694A1 (en) Cartilage repair apparatus and method
AU2002316694A1 (en) Hybrid biologic/synthetic porous extracellular matrix scaffolds

Legal Events

Date Code Title Description
AS Assignment

Owner name: DEPUY PRODUCTS, INC., INDIANA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PLOUHAR, PAMELA L.;SCHWARTZ, HERBERT E.;MALAVIYA, PRASANNA;REEL/FRAME:023809/0475;SIGNING DATES FROM 20050802 TO 20090806

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION